10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________________________

FORM 10-Q

________________________________________________________

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-38462

________________________________________________________

NLIGHT, INC.

(Exact name of Registrant as specified in its charter)

________________________________________________________

Delaware	91-2066376
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

4637 NW 18th Avenue

Camas, Washington 98607

(Address of principal executive office, including zip code)

(360) 566-4460

(Registrant's telephone number, including area code)

__________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol	Name of Exchange on which Registered
Common Stock, par value $0.0001 per share	LASR	The Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).                     Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.    

Large Accelerated Filer	☐	Accelerated Filer	☒	Non-Accelerated Filer	☐	Smaller Reporting Company	☐
						Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.         ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes ☐    No ☒

As of May 2, 2023, the Registrant had 45,850,661 shares of common stock outstanding.

TABLE OF CONTENTS
	Page
Part I. Financial Information	1
Item 1. Unaudited Interim Financial Statements	1
Consolidated Balance Sheets: March 31, 2023 and December 31, 2022 (unaudited)	1
Consolidated Statements of Operations: Three Months Ended March 31, 2023 and 2022 (unaudited)	2
Consolidated Statements of Comprehensive Loss: Three Months Ended March 31, 2023 and 2022 (unaudited)	3
Consolidated Statements of Stockholders' Equity: Three Months Ended March 31, 2023 and 2022 (unaudited)	4
Consolidated Statements of Cash Flows: Three Months Ended March 31, 2023 and 2022 (unaudited)	5
Notes to Consolidated Financial Statements (unaudited)	6
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3. Quantitative and Qualitative Disclosures About Market Risk	22
Item 4. Controls and Procedures	22
Part II. Other Information	22
Item 1. Legal Proceedings	22
Item 1A. Risk Factors	22
Item 6. Exhibits	23
Signatures	24

PART I

ITEM 1. FINANCIAL STATEMENTS

nLIGHT, Inc.

Consolidated Balance Sheets

(In thousands)

(Unaudited)

	As of
	March 31, 2023		December 31, 2022
Assets
Current assets:
Cash and cash equivalents	$	48,402	$	57,826
Marketable securities	59,966		50,391
Accounts receivable, net of allowances of $290 and $290	36,140		37,913
Inventory	67,157		67,600
Prepaid expenses and other current assets	21,586		17,026
Total current assets	233,251		230,756
Restricted cash	253		252
Lease right-of-use assets	13,900		13,893
Property, plant and equipment, net	58,978		60,693
Intangible assets, net	3,408		4,041
Goodwill	12,388		12,376
Other assets, net	7,586		7,222
Total assets	$	329,764	$	329,233
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	17,759	$	17,507
Accrued liabilities	14,708		12,820
Deferred revenues	1,271		1,407
Current portion of lease liabilities	3,001		2,758
Total current liabilities	36,739		34,492
Non-current income taxes payable	6,920		6,699
Long-term lease liabilities	12,576		12,852
Other long-term liabilities	4,367		4,345
Total liabilities	60,602		58,388
Stockholders' equity:
Common stock - $0.0001 par value; 190,000 shares authorized, 45,785 and 45,629 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	16		16
Additional paid-in capital	501,675		496,211
Accumulated other comprehensive loss	(2,165)		(2,748)
Accumulated deficit	(230,364)		(222,634)
Total stockholders’ equity	269,162		270,845
Total liabilities and stockholders’ equity	$	329,764	$	329,233

See accompanying notes to consolidated financial statements.

1

nLIGHT, Inc.

Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

	Three Months Ended March 31,
	2023		2022
Revenue:
Products	$	41,107	$	51,061
Development	12,984		13,398
Total revenue	54,091		64,459
Cost of revenue:
Products	27,526		35,768
Development	12,302		12,514
Total cost of revenue	39,828		48,282
Gross profit	14,263		16,177
Operating expenses:
Research and development	11,301		13,711
Sales, general, and administrative	11,169		10,775
Total operating expenses	22,470		24,486
Loss from operations	(8,207)		(8,309)
Other income:
Interest income, net	337		—
Other income, net	404		29
Loss before income taxes	(7,466)		(8,280)
Income tax expense	264		343
Net loss	$	(7,730)	$	(8,623)
Net loss per share, basic and diluted	$	(0.17)	$	(0.20)
Shares used in per share calculations, basic and diluted	45,706		43,655

See accompanying notes to consolidated financial statements.

2

nLIGHT, Inc.

Consolidated Statements of Comprehensive Loss

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2023		2022
Net loss	$	(7,730)	$	(8,623)
Other comprehensive loss, net of tax:
Foreign currency translation adjustments	369		(96)
Unrealized gains on available-for-sale securities	214		—
Comprehensive loss	$	(7,147)	$	(8,719)

See accompanying notes to consolidated financial statements.

3

nLIGHT, Inc.

Consolidated Statements of Stockholders' Equity

(In thousands)

(Unaudited)

	Three Months Ended March 31, 2023
	Common stock			Additional paid-in capital		Accumulated other comprehensive loss		Accumulated deficit		Total stockholders' equity
	Shares	Amount
Balance, December 31, 2022	45,629	$	16	$	496,211	$	(2,748)	$	(222,634)	$	270,845
Net loss	—	—		—		—		(7,730)		(7,730)
Issuance of common stock pursuant to exercise of stock options	117	—		143		—		—		143
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax	39	—		(182)		—		—		(182)
Stock-based compensation	—	—		5,503		—		—		5,503
Unrealized gains on available-for-sale securities	—	—		—		214		—		214
Cumulative translation adjustment, net of tax	—	—		—		369		—		369
Balance, March 31, 2023	45,785	$	16	$	501,675	$	(2,165)	$	(230,364)	$	269,162

	Three Months Ended March 31, 2022
	Common stock			Additional paid-in capital		Accumulated other comprehensive loss		Accumulated deficit		Total stockholders' equity
	Shares	Amount
Balance, December 31, 2021	44,248	$	15	$	470,760	$	(587)	$	(168,055)	$	302,133
Net loss	—	—		—		—		(8,623)		(8,623)
Issuance of common stock pursuant to exercise of stock options	423	—		689		—		—		689
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax	7	—		(78)		—		—		(78)
Restricted stock awards forfeited in connection with transition agreement	(140)	—		—		—		—		—
Stock-based compensation	—	—		6,553		—		—		6,553
Cumulative translation adjustment, net of tax	—	—		—		(96)		—		(96)
Balance, March 31, 2022	44,538	$	15	$	477,924	$	(683)	$	(176,678)	$	300,578

See accompanying notes to consolidated financial statements.

4

nLIGHT, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2023		2022
Cash flows from operating activities:
Net loss	$	(7,730)	$	(8,623)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	3,105		2,556
Amortization	872		1,182
Reduction in carrying amount of right-of-use assets	6		867
Recoveries of losses on accounts receivable	(2)		—
Stock-based compensation	5,503		6,553
Deferred income taxes	—		(4)
Changes in operating assets and liabilities:
Accounts receivable, net	1,905		4,690
Inventory	662		(3,433)
Prepaid expenses and other current assets	(4,549)		(5,061)
Other assets, net	(540)		(317)
Accounts payable	(411)		(3,019)
Accrued and other long-term liabilities	1,855		(1,088)
Deferred revenues	(142)		(647)
Lease liabilities	(45)		(813)
Non-current income taxes payable	155		153
Net cash provided by (used in) operating activities	644		(7,004)
Cash flows from investing activities:
Purchases of property, plant and equipment	(684)		(5,019)
Acquisition of intangible assets and capitalization of patents	—		(114)
Purchase of marketable securities	(34,359)		—
Proceeds from maturities and sales of marketable securities	24,998		—
Net cash used in investing activities	(10,045)		(5,133)
Cash flows from financing activities:
Proceeds from stock option exercises	143		689
Tax payments related to stock award issuances	(182)		(78)
Net cash (used in) provided by financing activities	(39)		611
Effect of exchange rate changes on cash	17		(59)
Net decrease in cash, cash equivalents, and restricted cash	(9,423)		(11,585)
Cash, cash equivalents, and restricted cash, beginning of period	58,078		146,784
Cash, cash equivalents, and restricted cash, end of period	$	48,655	$	135,199
Supplemental disclosures:
Cash paid for interest, net	$	—	$	—
Cash paid for income taxes	144		79
Operating cash outflows from operating leases	923		1,097
Right-of-use assets obtained in exchange for lease liabilities	731		1,470
Accrued purchases of property, equipment and patents	697		2,268

See accompanying notes to consolidated financial statements.

5

nLIGHT, Inc.

Notes to Consolidated Financial Statements

Note 1 - Basis of Presentation and New Accounting Pronouncements

Basis of Presentation

The accompanying unaudited consolidated financial statements of nLIGHT, Inc. and our wholly-owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The unaudited financial information reflects, in the opinion of management, all adjustments necessary for a fair presentation of financial position, results of operations, stockholders’ equity, and cash flows for the interim periods presented. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.

Critical Accounting Policies

Our critical accounting policies have not materially changed during the three months ended March 31, 2023, from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

New Accounting Pronouncements

None.

Note 2 - Revenue

We recognize revenue upon transferring control of products and services and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. As part of our consideration of the contract, we evaluate certain factors, including the customer's ability to pay (or credit risk). For each contract, we consider the promise to transfer products, each of which is distinct, as the identified performance obligations.

We allocate the transaction price to each distinct product based on its relative standalone selling price. Master sales agreements or purchase orders from customers could include a single product or multiple products. Regardless, the contracted price with the customer is agreed to at the individual product level outlined in the customer contract or purchase order. We do not bundle prices; however, we do negotiate with customers on pricing for the same products based on a variety of factors (e.g., level of contractual volume). We have concluded that the prices negotiated with each individual customer are representative of the stand-alone selling price of the product.

We often receive orders with multiple delivery dates that may extend across several reporting periods. We allocate the transaction price of the contract to each delivery based on the product standalone selling price and invoice for each scheduled delivery upon shipment or delivery and recognize revenues for such delivery at that point, when transfer of control has occurred. As scheduled delivery dates are generally within one year, under the optional exemption provided by ASC 606-10-50-14a revenues allocated to future shipments of partially completed contracts are not disclosed as performance obligations for point in time revenue. Further, the Company recognizes over time revenue as per ASC 606-10-55-18 (invoice practical expedient) for its cost plus contracts and, accordingly, elects not to disclose information related to those performance obligations under ASC 606-10-50-14b.

Rights of return generally are not included in customer contracts. Accordingly, product revenue is recognized upon transfer of control at shipment or delivery, as applicable. Rights of return are evaluated as they occur.

Revenues recognized at a point in time consist of sales of semiconductor lasers, fiber lasers and other related products. Revenues recognized over time generally consist of development arrangements that are structured based on our costs incurred. Because control transfers over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. We generally use the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer. Billing under these arrangements generally occurs within one month after the work is completed.

6

The following tables represent a disaggregation of revenue from contracts with customers for the periods presented (in thousands):

Sales by End Market

	Three Months Ended March 31,
	2023		2022
Industrial	$	19,902	$	23,996
Microfabrication	13,058		17,319
Aerospace and Defense	21,131		23,144
	$	54,091	$	64,459

Sales by Geography

	Three Months Ended March 31,
	2023		2022
North America	$	29,103	$	35,144
China	3,646		7,139
Rest of World	21,342		22,176
	$	54,091	$	64,459

Sales by Timing of Revenue

	Three Months Ended March 31,
	2023		2022
Point in time	$	40,272	$	48,215
Over time	13,819		16,244
	$	54,091	$	64,459

Our contract assets and liabilities are as follows (in thousands):

	Balance Sheet Classification	As of
		March 31, 2023		December 31, 2022
Contract assets	Prepaid expenses and other current assets	$	16,547	$	10,377
Contract liabilities	Deferred revenues and other long-term liabilities	2,511		2,455

Contract assets generally consist of revenue recognized on an over time basis where revenue recognition has been met, but the amounts are subsequently billed and collected in the following period.

During the three months ended March 31, 2023 and 2022, we recognized revenue of $0.8 million and $1.4 million, respectively, that was included in the deferred revenue balances at the beginning of the period as the performance obligations under the associated agreements were satisfied.

7

Note 3 - Concentrations of Credit and Other Risks

The following customers accounted for 10% or more of our revenues for the periods presented:

	Three Months Ended March 31,
	2023	2022
U.S. Government	16%	17%
Raytheon Technologies	(1)	10%

(1)Represents less than 10% of total revenues.

Financial instruments that potentially expose us to concentrations of credit risk consist principally of receivables from customers. As of March 31, 2023, and December 31 2022, two customers accounted for a total of 33% and 29%, respectively, of net customer receivables. No other customers accounted for 10% or more of net customer receivables at either date. 

Note 4 - Marketable Securities

Marketable securities consist primarily of highly liquid investments with original maturities of greater than 90 days when purchased. Our marketable securities are considered available-for-sale as they represent investments that are available to be sold for current operations. As such, they are included as current assets on our Consolidated Balance Sheets at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Any unrealized gains and losses that are considered to be other-than-temporary are recorded in other income, net on our Consolidated Statements of Operations. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in other income, net on our Consolidated Statements of Operations.

Realized gains were $0.4 million for three months ended March 31, 2023. Unrealized gains were $0.2 million for the three months ended March 31, 2023. These unrealized gains are considered temporary and are reflected in the Statements of Comprehensive Loss. There were no realized or unrealized gains or losses for the three months ended March 31, 2022.

See Note 5 for additional information.

Note 5 - Fair Value of Financial Instruments

The carrying amounts of certain of our financial instruments, including cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities are shown at cost which approximates fair value due to the short-term nature of these instruments. The fair value of our term and revolving loans approximates the carrying value due to the variable market rate used to calculate interest payments.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value which are the following:

•Level 1 Inputs: Observable inputs, such as quoted prices (unadjusted) in active markets for identical assets or liabilities at the measurement date.

•Level 2 Inputs: Observable inputs, other than Level 1 prices, such as quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•Level 3 Inputs: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

8

Our financial instruments that are carried at fair value consist of Level 1 assets which include highly liquid investments and bank drafts classified as cash equivalents and marketable securities.

Our fair value hierarchy for our financial instruments was as follows (in thousands):

	March 31, 2023
	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market securities	$	26,000	$	—	$	—	$	26,000
Commercial paper	557		—		—		557
	26,557		—		—		26,557
Marketable Securities:
U.S. treasuries	59,966		—		—		59,966
Total	$	86,523	$	—	$	—	$	86,523

	December 31, 2022
	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market securities	$	31,658	$	—	$	—	$	31,658
Commercial paper	656		—		—		656
	$	32,314	$	—	$	—	$	32,314
Marketable Securities:
U.S. treasuries	50,391		—		—		50,391
Total	$	82,705	$	—	$	—	$	82,705

Cash Equivalents

The fair value of cash equivalents is determined based on quoted market prices for similar or identical securities.

Marketable Securities

We classify our marketable securities as available-for-sale and value them utilizing a market approach that uses observable inputs without applying significant judgment.

Note 6 - Inventory

Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

Inventory consisted of the following (in thousands):

	As of
	March 31, 2023		December 31, 2022
Raw materials	$	32,665	$	32,515
Work in process and semi-finished goods	20,137		19,056
Finished goods	14,355		16,029
	$	67,157	$	67,600

9

Note 7 - Property, Plant and Equipment

Property, plant and equipment consist of the following (in thousands):

	Useful life	As of
	(years)	March 31, 2023		December 31, 2022
Automobiles	3	$	114	$	110
Computer hardware and software	3 - 5	8,673		8,712
Manufacturing and lab equipment	2 - 7	90,153		89,230
Office equipment and furniture	5 - 7	2,482		2,410
Leasehold and building improvements	2 - 12	31,217		30,675
Buildings	30	9,392		9,392
Land	N/A	3,399		3,399
		145,430		143,928
Accumulated depreciation		(86,452)		(83,235)
		$	58,978	$	60,693

Note 8 - Intangible Assets and Goodwill

Intangible Assets

The details of definite lived intangible assets were as follows (in thousands):

	Estimated useful life (in years)	As of
		March 31, 2023		December 31, 2022
Patents	3 - 5	$	6,334	$	6,322
Development programs	2 - 4	7,200		7,200
Developed technology	5	2,960		2,930
		16,494		16,452
Accumulated amortization		(13,086)		(12,411)
		$	3,408	$	4,041

Amortization related to intangible assets was as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Amortization expense	$	654	$	776

Estimated amortization expense for future years is as follows (in thousands):

2023	$	1,581
2024	929
2025	593
2026	305
Thereafter	—
	$	3,408

10

Goodwill

The carrying amount of goodwill by segment was as follows (in thousands):

	Laser Products		Advanced Development		Totals
Balance, December 31, 2022	$	2,128	$	10,248	$	12,376
Currency exchange rate adjustment	12		—		12
Balance, March 31, 2023	$	2,140	$	10,248	$	12,388

Note 9 - Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

	As of
	March 31, 2023		December 31, 2022
Accrued payroll and benefits	$	9,888	$	8,233
Product warranty, current	2,540		2,601
Other accrued expenses	2,280		1,986
	$	14,708	$	12,820

Note 10 - Product Warranties

We provide warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based on historical experience, any specifically identified failures, and our estimate of future costs. The current portion of our product warranty liability is included in the accrued liabilities and the long-term portion is included in other long-term liabilities in our Consolidated Balance Sheets.

Product warranty liability activity was as follows for the periods presented (in thousands):

	Three Months Ended March 31,
	2023		2022
Product warranty liability, beginning	$	5,441	$	5,371
Warranty charges incurred, net	(782)		(1,490)
Provision for warranty charges, net of adjustments	572		1,560
Product warranty liability, ending	5,231		5,441
Less: current portion of product warranty liability	(2,540)		(2,601)
Non-current portion of product warranty liability	$	2,691	$	2,840

Note 11 - Stockholders' Equity and Stock-Based Compensation

Restricted Stock Awards and Units

There was no restricted stock award activity in the first quarter of 2023. Restricted stock unit ("RSU") activity under our equity incentive plan was as follows (in thousands, except weighted-average grant date fair values):

		Number of Restricted Stock Units	Weighted-Average Grant Date Fair Value
RSUs at December 31, 2022		2,784	$	17.63
	Awards granted	152	11.55
	Awards vested	(57)	18.09
	Awards forfeited	(223)	21.49
RSUs at March 31, 2023		2,656	16.95

11

The total fair value of RSUs vested during the three months ended March 31, 2023, was $1.0 million. Awards outstanding as of March 31, 2023 include 0.6 million performance-based awards that will vest upon meeting certain performance criteria.

Stock Options

The following table summarizes our stock option activity during the three months ended March 31, 2023 (in thousands, except weighted-average exercise prices):

	Number of Options	Weighted-Average Exercise Price	Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding, December 31, 2022	1,827	$1.29	3.4	$16,156
Options exercised	(117)	1.22
Outstanding, March 31, 2023	1,710	1.30	3.2	15,181
Options exercisable at March 31, 2023	1,710	1.30	3.2	15,181
Options vested as of March 31, 2023, and expected to vest after March 31, 2023	1,710	1.30	3.2	15,181

Total intrinsic value of options exercised for the three months ended March 31, 2023 and 2022, was $1.1 million and $6.4 million, respectively. We received proceeds of $0.1 million and $0.7 million from the exercise of options for the three months ended March 31, 2023 and 2022, respectively.

Stock-Based Compensation

Total stock-based compensation expense was included in our consolidated statements of operations as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Cost of revenues	$	700	$	709
Research and development	2,098		3,122
Sales, general and administrative	2,705		2,722
	$	5,503	$	6,553

Unrecognized Compensation Costs

As of March 31, 2023, total unrecognized stock-based compensation was $34.8 million, which will be recognized over an average expected recognition period of 2.0 years.

Note 12 - Commitments and Contingencies

Leases

See Note 13.

Legal Matters

On March 25, 2022, Lumentum Operations LLC filed a complaint against nLIGHT, Inc. and certain of its employees in the U.S. District Court for the Western District of Washington. The complaint alleges that Lumentum is the partial or full owner of certain of our patents and requests corresponding relief from the court. We are vigorously defending against Lumentum’s allegations. Loss in this matter is not probable or reasonably estimable and, as such, no loss contingency has been recorded.

From time to time, we may be subject to various other legal proceedings and claims in the ordinary course of business. As of March 31, 2023, we believe these matters will not have a material adverse effect on our consolidated financial statements.

12

Note 13 - Leases

We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space. Facilities-related operating leases have remaining terms of one month to 12.2 years, and some leases include options to extend up to 15 years. Other leases for automobiles, manufacturing and office and computer equipment have remaining lease terms of 0.2 to 4.3 years. These leases are primarily operating leases; financing leases are not material. We did not include any renewal options in our lease terms for calculating the lease liabilities as we are not reasonably certain we will exercise the options at this time. The weighted-average remaining lease term for the lease obligations was 8 years as of March 31, 2023, and the weighted-average discount rate was 3.6%. The weighted-average remaining lease term for the lease obligations was 8 years as of December 31, 2022, and the weighted-average discount rate was 3.6%.

The components of lease expense related to operating leases were as follows (in thousands):

		Three Months Ended March 31,
		2023		2022
Lease expense:
	Operating lease expense	$	921	$	1,031
	Short-term lease expense	93		121
	Variable and other lease expense	225		194
		$	1,239	$	1,346

Future minimum payments under our non-cancelable lease obligations were as follows as of March 31, 2023 (in thousands):

2023	$	2,658
2024	3,232
2025	2,067
2026	1,654
2027	1,655
Thereafter	6,806
Total minimum lease payments	18,072
Less: interest	(2,495)
Present value of net minimum lease payments	15,577
Less: current portion of lease liabilities	(3,001)
Total long-term lease liabilities	$	12,576

Note 14 - Segment Information

We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. The following table summarizes the operating results by reportable segment (dollars in thousands):

	Three Months Ended March 31, 2023
	Laser Products			Advanced Development			Corporate and Other		Totals
Revenue	$	41,107		$	12,984		$	—	$	54,091
Gross profit	$	14,281		$	682		$	(700)	$	14,263
Gross margin	34.7		%	5.3		%	NM*		26.4		%

13

	Three Months Ended March 31, 2022
	Laser Products			Advanced Development			Corporate and Other		Totals
Revenue	$	51,061		$	13,398		$	—	$	64,459
Gross profit	$	16,002		$	884		$	(709)	$	16,177
Gross margin	31.3		%	6.6		%	NM*		25.1		%

Corporate and Other is unallocated expenses related to stock-based compensation.

There have been no material changes to the geographic locations of our long-lived assets, net, based on the location of the assets, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

Note 15 - Net Loss per Share

Basic and diluted net loss and the number of shares used for basic and diluted net loss calculations were the same for all periods presented because we were in a loss position.

The following potentially dilutive securities were not included in the calculation of diluted shares as the effect would have been anti‑dilutive (in thousands):

	Three Months Ended March 31,
	2023	2022
Restricted stock units and awards	845	1,313
Common stock options	1,574	2,090
	2,419	3,403

Note 16 - Subsequent Event

On May 4, 2023, we announced that we had been awarded an $86 million contract to produce a High Energy Laser (HEL) prototype for the next phase of development in support of the U.S. Department of Defense’s (DoD) High Energy Laser Scaling Initiative (HELSI). The award is part of a multi-year development program that is expected to commence in the third quarter of 2023.

14

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may," "objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.

These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our business model and strategic plans; our expectations regarding manufacturing; our future financial performance; demand for our semiconductor and fiber laser solutions; our ability to develop innovative products; our expectations regarding product volumes and the introduction of new products; our technology and new product research and development activities; the impact of inflation; the impact of seasonality; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs.

You should refer to the "Risk Factors" section of this report for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Overview

nLIGHT, Inc., is a leading provider of high‑power semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. Headquartered in Camas, Washington, we design, develop, and manufacture the critical elements of our lasers, and believe our vertically integrated business model enables us to rapidly introduce innovative products, control our costs and protect our intellectual property.

We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. Sales of our semiconductor lasers, fiber lasers, fiber amplifiers, and other directed energy laser products are included in the Laser Products segment, while revenue earned from research and development contracts are included in the Advanced Development segment.

Revenues decreased to $54.1 million in the three months ended March 31, 2023 compared to $64.5 million in the same period of 2022 due primarily to decreased sales in the Laser Products segment. We generated a net loss of $7.7 million for the three months ended March 31, 2023 compared to a net loss of $8.6 million for the same period of 2022.

15

Factors Affecting Our Performance

Demand for our Semiconductor and Fiber Laser Solutions

In order to continue to grow our revenues, we must continue to achieve design wins for our semiconductor and fiber lasers. We consider a design win to occur when a customer notifies us that it has selected one of our products to be incorporated into a product or system under development by such customer. For the foreseeable future, our operations will continue to depend upon capital expenditures by customers in the Industrial and Microfabrication markets, which, in turn, depend upon the demand for these customers’ products or services. In addition, in the Aerospace and Defense market, our business depends in large part on continued investment in laser technology by the U.S. government and its allies, and our ability to continue to successfully develop leading technology in this area and commercialize that technology in the future.

Demand for our products also fluctuates based on market cycles, continuously evolving industry supply chains, trade and tariff terms, as well as evolving competitive dynamics in each of our end-markets. Erosion of average selling prices, or ASPs, of established products is typical in our industry, and the ASPs of our products generally decrease as our products mature. We may also negotiate discounted selling prices from time to time with certain customers that purchase higher volumes, or to penetrate new markets or applications. Historically, we have been able to offset decreasing ASPs by introducing new and higher value products, increasing the sales of our existing products, expanding into new applications and reducing our product and manufacturing costs. Although we anticipate further increases in product volumes and the continued introduction of new and higher value products, ASP reduction may cause our revenues to decline or grow at a slower rate.

Technology and New Product Development

We invest heavily in the development of our semiconductor, fiber laser and directed energy technologies to provide solutions to our current and future customers. We anticipate that we will continue to invest in research and development to achieve our technology and product roadmap. Our product development is targeted to specific sectors of the market where we believe the performance of our products provide a significant benefit to our customers. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.

Manufacturing Costs and Gross Margins

Our product gross profit, in absolute dollars and as a percentage of revenues, is impacted by our product sales mix, sales volumes, changes in ASPs, production volumes, the corresponding absorption of manufacturing overhead expenses, production costs and manufacturing yields. Our product sales mix can affect gross profits due to variations in profitability related to product configurations and cost profiles, customer volume pricing, availability of competitive products in various markets, and new product introductions, among other factors. We have invested heavily in U.S.-based manufacturing capabilities in the last several years. Capacity utilization affects our gross margin because we have a high fixed cost base due to our vertically integrated business model. Increases in sales and production volumes drive favorable absorption of fixed costs, improved manufacturing efficiencies and lower production costs. Gross margins may fluctuate from period to period depending on product mix and the level of capacity utilization.

Our Development gross profit varies with the type and terms of contracts, contract volume, project mix, execution on projects during the period, and estimated costs to project completion. Most of our Development contracts are structured as cost plus fixed fee due to the technical complexity of the research and development services.

Seasonality

Our quarterly revenues can fluctuate with general economic trends, the timing of capital expenditures by our customers, holidays, and general economic trends. In addition, as is typical in our industry, we tend to recognize a larger percentage of our quarterly revenues in the last month of the quarter, which may impact our working capital trends.

16

Results of Operations

The following table sets forth our operating results as a percentage of revenues for the periods indicated (which may not add up due to rounding):

	Three Months Ended March 31,
	2023		2022
Revenue:
Products	76.0	%	79.2	%
Development	24.0		20.8
Total revenue	100.0		100.0
Cost of revenue:
Products	50.9		55.5
Development	22.7		19.4
Total cost of revenue	73.6		74.9
Gross profit	26.4		25.1
Operating expenses:
Research and development	20.9		21.3
Sales, general, and administrative	20.6		16.7
Total operating expenses	41.5		38.0
Loss from operations	(15.2)		(12.9)
Other income:
Interest income, net	0.6		—
Other income, net	0.7		—
Loss before income taxes	(13.8)		(12.9)
Income tax expense	0.5		0.5
Net loss	(14.3)	%	(13.4)	%

Revenues by End Market

Our revenues by end market were as follows for the periods presented (dollars in thousands):

	Three Months Ended March 31,								Change
	2023		% of Revenue		2022		% of Revenue		$		%
Industrial	$	19,902	36.8	%	$	23,996	37.2	%	$	(4,094)	(17.1)	%
Microfabrication	13,058		24.1		17,319		26.9		(4,261)		(24.6)
Aerospace and Defense	21,131		39.1		23,144		35.9		(2,013)		(8.7)
	$	54,091	100.0	%	$	64,459	100.0	%	$	(10,368)	(16.1)	%

The decreases in revenue from the Industrial and Microfabrication markets for the three months ended March 31, 2023 compared to the same period of 2022 were a result of decreased unit sales due to lower market demand, particularly in China. The decrease in revenue from the Aerospace and Defense market for the three months ended March 31, 2023 compared to the same period of 2022 was driven primarily by a decrease in unit sales and decreased activity on research and development contracts.

17

Revenues by Segment

Our revenues by segment were as follows for the periods presented (dollars in thousands):

	Three Months Ended March 31,								Change
	2023		% of Revenue		2022		% of Revenue		$		%
Laser Products	$	41,107	76.0	%	$	51,061	79.2	%	$	(9,954)	(19.5)	%
Advanced Development	12,984		24.0		13,398		20.8		(414)		(3.1)
	$	54,091	100.0	%	$	64,459	100.0	%	$	(10,368)	(16.1)	%

The decrease in Laser Products revenue for the three months ended March 31, 2023 compared to the same period of 2022 was driven by decreased units sales across each end market as discussed above. The decrease in Advanced Development revenue for the three months ended March 31, 2023 compared to the same period of 2022 was primarily due to decreased activity on research and development contracts. Most of our Advanced Development revenue is generated from cost plus fixed fee research and development contracts, and all Advanced Development revenue is included in the Aerospace and Defense market.

Revenues by Geographic Region

Our revenues by geographic region were as follows for the periods presented (dollars in thousands):

	Three Months Ended March 31,								Change
	2023		% of Revenue		2022		% of Revenue		$		%
North America	$	29,103	53.8	%	$	35,144	54.5	%	$	(6,041)	(17.2)	%
China	3,646		6.7		7,139		11.1		(3,493)		(48.9)
Rest of World	21,342		39.5		22,176		34.4		(834)		(3.8)
	$	54,091	100.0	%	$	64,459	100.0	%	$	(10,368)	(16.1)	%

Geographic revenue information is based on the location to which we ship our products. The decrease in North America revenue for the three months ended March 31, 2023 compared to the same period of 2022 was a result of decreased revenue across each end market as discussed above. The decrease in China revenue for the three months ended March 31, 2023 compared to the same period of 2022 was the result of decreased revenue from the Industrial and Microfabrication markets due to a decline in market conditions and our decision to exit the fiber laser cutting market in China during the fourth quarter of 2022. The decrease in Rest of World revenue for the three months ended March 31, 2023 compared to the same period of 2022 was due to decreased revenue from the Microfabrication market, partially offset by increased revenue from the Industrial market.

Cost of Revenues and Gross Margin

Cost of Laser Products revenue consists primarily of manufacturing materials, labor, shipping and handling costs, tariffs and manufacturing-related overhead. We order materials and supplies based on backlog and forecasted demand from our customers. We expense all warranty costs and inventory provisions as cost of revenues.

Cost of Advanced Development revenue consists of materials, labor, subcontracting costs, and an allocation of indirect costs including overhead and general and administrative.

18

Our gross profit and gross margin were as follows for the periods presented (dollars in thousands):

	Three Months Ended March 31, 2023
	Laser Products			Advanced Development			Corporate and Other		Total
Gross profit	$	14,153		$	682		$	(572)	$	14,263
Gross margin	34.4		%	5.3		%	NM*		26.4		%

	Three Months Ended March 31, 2022
	Laser Products			Advanced Development			Corporate and Other		Total
Gross profit	$	16,002		$	884		$	(709)	$	16,177
Gross margin	31.3		%	6.6		%	NM*		25.1		%

*NM = not meaningful

The increase in Laser Products gross margin for the three months ended March 31, 2023 compared to the same period of 2022 was driven by changes in sales mix, decreased unit sales of products for the Industrial market with low gross margins, and decreased manufacturing costs. The decrease in Advanced Development gross margin for the three months ended March 31, 2023 compared to the same period of 2022 was not significant and was primarily the result of changes in the mix of research and development contracts.

Operating Expenses

Our operating expenses were as follows for the periods presented (dollars in thousands):

Research and Development

	Three Months Ended March 31,				Change
	2023		2022		$		%
Research and development	$	11,301	$	13,711	$	(2,410)	(17.6)	%

The decrease in research and development expense for the three months ended March 31, 2023 compared to the same period in 2022 was driven by a decrease in salary costs and project-related expenses, a decrease in stock-based compensation of $1.0 million and a decrease in purchased intangible amortization of $0.1 million.

Sales, General and Administrative

	Three Months Ended March 31,				Change
	2023		2022		$		%
Sales, general, and administrative	$	11,169	$	10,775	$	394	3.7	%

The increase in sales, general and administrative expense for the three months ended March 31, 2023 compared to the same period in 2022 was primarily due to increases in rep commissions, professional service fees, and trade show related expenses.

19

Interest Income, net

	Three Months Ended March 31,				Change
	2023		2022		$		%
Interest income, net	$	337	$	—	$	337	—%

The increase in interest income, net, for the three months ended March 31, 2023 compared to the same period in 2022 was driven by an increase in interest rates and the investment in marketable securities during the second quarter of 2022.

Other Income, net

	Three Months Ended March 31,				Change
	2023		2022		$		%
Other income, net	$	404	$	29	$	375	1,293.1%

Changes in other income, net are primarily attributable to realized gains and losses on the sale of marketable securities and changes in net realized and unrealized foreign exchange transactions resulting from currency rate fluctuations. The increase in other income, net for the three months ended March 31, 2023 compared to the same period in 2022 was primarily due to realized gains on the sale of marketable securities.

Income Tax Expense

	Three Months Ended March 31,				Change
	2023		2022		$		%
Income tax expense	$	264	$	343	$	(79)	(23.0)	%

We record income tax expense for taxes in our foreign jurisdictions including Finland, Italy, and South Korea. While our tax expense is largely dependent on the geographic mix of earnings related to our foreign operations, we also record tax expense for uncertain tax positions taken and associated penalties and interest. We consider all available evidence, both positive and negative, in assessing the extent to which a valuation allowance should be applied against our deferred tax assets. Due to the uncertainty with respect to their ultimate realizability in the United States, Austria, and China, we continue to maintain a full valuation allowance in these jurisdictions as of March 31, 2023.

There was no significant change in income tax expense for the three months ended March 31, 2023 compared to the same period in 2022.

Liquidity and Capital Resources

We had cash and cash equivalents of $48.4 million and $57.8 million as of March 31, 2023 and December 31, 2022, respectively. In addition, we had marketable securities of $60.0 million and $50.4 million at March 31, 2023 and December 31, 2022, respectively.

For the three months ended March 31, 2023, our principal uses of liquidity were to fund our working capital needs. The primary source of cash was collections from customers. We believe our existing sources of liquidity will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts, the expansion of sales and marketing activities, the continuing market acceptance of our products and ongoing investments to support the growth of our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, technologies and intellectual property rights. From time to time, we may explore additional financing sources which could include equity, equity‑linked and debt financing arrangements.

20

The following table summarizes our cash flows for the periods presented (in thousands):

	Three Months Ended March 31,
	2023		2022
Net cash provided by (used in) operating activities	$	644	$	(7,004)
Net cash used in investing activities	(10,045)		(5,133)
Net cash (used in) provided by financing activities	(39)		611
Effect of exchange rate changes on cash	17		(59)
Net decrease in cash, cash equivalents and restricted cash	$	(9,423)	$	(11,585)

Net Cash Provided by (Used in) Operating Activities

During the three months ended March 31, 2023, net cash provided by operating activities was $0.6 million, which was the result of an $7.7 million net loss and use of cash for working capital of $1.1 million, offset by non-cash expenses totaling $9.5 million related primarily to depreciation, amortization, and stock-based compensation.

Changes in working capital were driven by a $4.5 million increase in prepaid expenses and other current assets, which was partially offset by a $2.1 million increase in accrued expenses and other long-term liabilities and a $1.9 million decrease in accounts receivable, net. The increase in prepaid expenses and other current assets related primarily to contract assets that will be billed in the second quarter of 2023, and the increase in accrued expenses and other long-term liabilities was driven by the timing of payroll related payments and the employee stock purchase plan.

Net Cash Used in Investing Activities

During the three months ended March 31, 2023, net cash used in investing activities was $10.0 million, which was driven by the net purchase of marketable securities of $9.4 million and capital expenditures of $0.7 million.

Net Cash Provided by (Used in) Financing Activities

During the three months ended March 31, 2023, net cash used in financing activities was less than $0.1 million.

Credit Facilities

We have a $40.0 million revolving line of credit, or LOC, with Pacific Western Bank dated September 24, 2018, which is secured by our assets and matures September 24, 2024.

The LOC agreement contains restrictive and financial covenants and bears an unused credit fee of 0.20% on an annualized basis. The interest rate on the LOC is based on the Prime Rate, minus a margin based on our liquidity levels. No amounts were outstanding under the LOC at March 31, 2023 and we were in compliance with all covenants.

Contractual Obligations

There have been no material changes to our contractual obligations as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

Inflation

While we do not believe that inflation had a material effect on our business, financial condition or results of operations during the three months ended March 31, 2023, we experienced increases in wages and other compensation costs, materials, and shipping costs in 2022. We expect costs will continue to increase in 2023 and continue to impact our cost structure. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could materially adversely affect our business, financial condition and results of operations.

21

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” contained in Part II of our Annual Report on Form 10-K for the year ended December 31, 2022. Our exposure to market risk has not changed materially since December 31, 2022.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and our chief financial officer, have evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our chief executive officer and our chief financial officer have concluded that, as of such date, our disclosure controls and procedures were, in design and operation, effective.

Changes in Internal Control over Financial Reporting

In January 2023, we launched our new enterprise resource planning (“ERP”) system and consequently, modified the design of certain internal controls over activities related to accumulation, recording and reporting of information in our financial statements. Other than these ERP system implementation changes, there have been no other changes in our internal controls over financial reporting that occurred during the first quarter of 2023 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

Limitations on the Effectiveness of Internal Control

Control systems, including ours, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.

PART II

ITEM 1. LEGAL PROCEEDINGS

For a description of our material pending legal proceedings, see Note 12, Commitments and Contingencies, to our consolidated financial statements included elsewhere in this report.

ITEM 1A. RISK FACTORS

For risk factors related to our business, reference is made to Item 1A, "Risk Factors," contained in Part I of our Annual Report on Form 10-K for the year ended December 31, 2022. There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

22

ITEM 6. EXHIBITS

(a) Exhibits

Exhibit Number		Incorporated by Reference				Filed Herewith
	Description	Form	File No.	Exhibit	Filing Date
3.2+	Amended and Restated Bylaws of the Registrant					X
31.1	Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002					X
31.2	Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002					X
32.1*	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002					X
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)					X
101.SCH	Inline XBRL Taxonomy Extension Schema Document					X
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.					X
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document					X
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document					X
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document					X
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)					X

+	This exhibit was originally filed as Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed on December 20, 2022. It is being refiled with this Quarterly Report on Form 10-Q solely to correct formatting errors to the section numbering in the original filing as it appears on EDGAR. No changes were made to the actual Amended and Restated Bylaws of the registrant since the original filing.
*	The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.

23

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		NLIGHT, INC.
		(Registrant)
May 5, 2023	By:	/s/ SCOTT KEENEY
Date		Scott Keeney
		President and Chief Executive Officer (Principal Executive Officer)
May 5, 2023	By:	/s/ JOSEPH CORSO
Date		Joseph Corso
		Chief Financial Officer (Principal Financial Officer)
May 5, 2023	By:	/s/ JAMES NIAS
Date		James Nias
		Chief Accounting Officer (Principal Accounting Officer)

24

EX-3.2

Exhibit 3.2

AMENDED AND RESTATED BYLAWS OF

NLIGHT, INC.

(As amended and restated on December 15, 2022)

TABLE OF CONTENTS

Page

ARTICLE I - CORPORATE OFFICES	1
1.1REGISTERED OFFICE	1
1.2OTHER OFFICES	1
ARTICLE II - MEETINGS OF STOCKHOLDERS	1
2.1PLACE OF MEETINGS	1
2.2ANNUAL MEETING	1
2.3SPECIAL MEETING	1
2.4ADVANCE NOTICE PROCEDURES	2
2.5NOTICE OF STOCKHOLDERS’ MEETINGS	9
2.6QUORUM	9
2.7ADJOURNED MEETING; NOTICE	9
2.8CONDUCT OF BUSINESS	9
2.9VOTING	10
2.10STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING	10
2.11RECORD DATES	10
2.12PROXIES	11
2.13LIST OF STOCKHOLDERS ENTITLED TO VOTE	11
2.14INSPECTORS OF ELECTION	11
ARTICLE III - DIRECTORS	12
3.1POWERS	12

- i -

TABLE OF CONTENTS

(continued)

Page

3.2NUMBER OF DIRECTORS	12
3.3ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS	12
3.4RESIGNATION AND VACANCIES	12
3.5PLACE OF MEETINGS; MEETINGS BY TELEPHONE	13
3.6REGULAR MEETINGS	13
3.7SPECIAL MEETINGS; NOTICE	13
3.8QUORUM; VOTING	14
3.9BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING	14
3.10FEES AND COMPENSATION OF DIRECTORS	14
3.11REMOVAL OF DIRECTORS	14
ARTICLE IV - COMMITTEES	14
4.1COMMITTEES OF DIRECTORS	14
4.2COMMITTEE MINUTES	15
4.3MEETINGS AND ACTION OF COMMITTEES	15
4.4SUBCOMMITTEES	15
ARTICLE V - OFFICERS	16
5.1OFFICERS	16
5.2APPOINTMENT OF OFFICERS	16
5.3SUBORDINATE OFFICERS	16
5.4REMOVAL AND RESIGNATION OF OFFICERS	16
5.5VACANCIES IN OFFICES	16

- ii -

TABLE OF CONTENTS

(continued)

Page

5.6REPRESENTATION OF SECURITIES OF OTHER ENTITIES	16
5.7AUTHORITY AND DUTIES OF OFFICERS	17
ARTICLE VI - STOCK	17
6.1STOCK CERTIFICATES; PARTLY PAID SHARES	17
6.2SPECIAL DESIGNATION ON CERTIFICATES	17
6.3LOST CERTIFICATES	18
6.4DIVIDENDS	18
6.5TRANSFER OF STOCK	18
6.6STOCK TRANSFER AGREEMENTS	18
6.7REGISTERED STOCKHOLDERS	18
ARTICLE VII - MANNER OF GIVING NOTICE AND WAIVER	19
7.1NOTICE OF STOCKHOLDERS’ MEETINGS	19
7.2NOTICE TO STOCKHOLDERS SHARING AN ADDRESS	19
7.3NOTICE TO PERSON WITH WHOM COMMUNICATION IS UNLAWFUL	19
7.4WAIVER OF NOTICE	19
ARTICLE VIII - INDEMNIFICATION	19
8.1INDEMNIFICATION OF DIRECTORS AND OFFICERS IN THIRD PARTY PROCEEDINGS	19
8.2INDEMNIFICATION OF DIRECTORS AND OFFICERS IN ACTIONS BY OR IN THE RIGHT OF THE CORPORATION	20
8.3SUCCESSFUL DEFENSE	20
8.4INDEMNIFICATION OF OTHERS	20

- iii -

TABLE OF CONTENTS

(continued)

Page

8.5ADVANCED PAYMENT OF EXPENSES	20
8.6LIMITATION ON INDEMNIFICATION	21
8.7DETERMINATION; CLAIM	21
8.8NON-EXCLUSIVITY OF RIGHTS	22
8.9INSURANCE	22
8.10SURVIVAL	22
8.11EFFECT OF REPEAL OR MODIFICATION	22
8.12CERTAIN DEFINITIONS	22
ARTICLE IX - GENERAL MATTERS	23
9.1EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS	23
9.2FISCAL YEAR	23
9.3SEAL	23
9.4CONSTRUCTION; DEFINITIONS	23
9.5FORUM	23
ARTICLE X - AMENDMENTS	24

- iv -

BYLAWS OF NLIGHT, INC.

ARTICLE I - CORPORATE OFFICES

1.1    REGISTERED OFFICE

The registered office of nLIGHT, Inc. (the “corporation”) shall be fixed in the corporation’s certificate of incorporation, as the same may be amended from time to time (the “certificate of incorporation”).

1.2    OTHER OFFICES

The corporation may at any time establish other offices at any place or places.

ARTICLE II - MEETINGS OF STOCKHOLDERS

2.1    PLACE OF MEETINGS

Meetings of stockholders shall be held at any place, within or outside the State of Delaware, designated by the corporation’s board of directors (the “board of directors”). The board of directors may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section 211(a)(2) of the Delaware General Corporation Law (the “DGCL”). In the absence of any such designation or determination, stockholders’ meetings shall be held at the corporation’s principal executive office.

2.2    ANNUAL MEETING

The annual meeting of stockholders shall be held each year on such date, at such time, and at such place (if any) within or without the State of Delaware as shall be designated from time to time by the board of directors and stated in the corporation’s notice of the meeting. At the annual meeting, directors shall be elected and any other proper business, brought in accordance with Section 2.4 of these bylaws, may be transacted. The board of directors, acting pursuant to a resolution adopted by a majority of the Whole Board, or the chairperson of the meeting, may cancel, postpone or reschedule any previously scheduled annual meeting of stockholders at any time, before or after the notice for such meeting has been sent to the stockholders. For purposes of these bylaws, the term “Whole Board” shall mean the total number of authorized directors whether or not there exist any vacancies or other unfilled seats in previously authorized directorships.

2.3    SPECIAL MEETING

(i)    Subject to the rights of holders of any series of preferred stock of the corporation (“Preferred Stock”),a special meeting of the stockholders, other than those required by statute, may be called at any time by (A) the board of directors acting pursuant to a resolution adopted by a majority of the Whole Board, (B) the chairperson of the board of directors or (C) the chief executive officer or president (in the absence of a chief executive officer), but a special meeting may not be called by any other person or persons. The board of directors, acting pursuant to a resolution adopted by a majority of the Whole Board, or the chairperson of the meeting, may cancel, postpone or reschedule any previously scheduled special meeting at any time, before or after the notice for such meeting has been sent to the stockholders.

(ii)    The notice of a special meeting shall include the purpose for which the meeting is called. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting by or at the direction of the board of directors, acting pursuant to a resolution adopted by a majority of the Whole Board, chairperson of the board of directors, chief executive officer or president (in the absence of a chief executive officer). Nothing contained in this Section 2.3(ii) shall be construed as limiting, fixing or affecting the time when a meeting of stockholders called by action of the board of directors may be held.

2.4    ADVANCE NOTICE PROCEDURES

(i)    Advance Notice of Stockholder Business at Annual Meeting. At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, business must be brought: (A) pursuant to the corporation’s notice of the annual meeting (or any supplement thereto) with respect to such meeting, (B) by or at the direction of the board of directors, or any committee thereof that has been formally delegated authority to propose such business pursuant to a resolution adopted by the affirmative vote of a majority of the Whole Board, (C) by a stockholder of the corporation who (1) is a stockholder of record at the time of the giving of the notice required by this Section 2.4(i), (2) is a stockholder of record on the record date for the determination of stockholders entitled to notice of the annual meeting, (3) is a stockholder of record on the record date for the determination of stockholders entitled to vote at the annual meeting, (4) is a stockholder of record at the time of the annual meeting, and (5) has timely complied in proper written form with the notice procedures set forth in this Section 2.4(i) or (D) as may be provided in the certificate of designations for any series of Preferred Stock. In addition, for business to be properly brought before an annual meeting by a stockholder, such business must be a proper matter for stockholder action pursuant to these bylaws and applicable law. For the avoidance of doubt, except for proposals properly made in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, and the rules and regulations thereunder (as amended and inclusive of such rules and regulations and any successors thereto (the “1934 Act”)), and subject to clause (D) above, clause (C) above shall be the exclusive means for a stockholder to bring business before an annual meeting of stockholders.

(a)    To comply with clause (C) of Section 2.4(i) above, a stockholder’s notice must set forth all information required under this Section 2.4(i) and must be timely received by the secretary of the corporation (the “Secretary”). To be timely, a stockholder’s notice must be received by the Secretary at the principal executive offices of the corporation not later than 5:00 p.m., Pacific time, on the 45th day nor earlier than 8:00 a.m., Pacific time, on the 75th day before the one-year anniversary of the date on which the corporation first mailed its proxy materials or a notice of availability of proxy materials (whichever is earlier) for the preceding year’s annual meeting; provided, however, that if no annual meeting was held in the previous year or if the date of the annual meeting for the current year has been changed by more than 25 days from the one-year anniversary of the date of the previous year’s annual meeting, then, for notice by the stockholder to be timely, it must be so received by the Secretary at the principal executive offices of the corporation not earlier than 8:00 a.m., Pacific time, on the 120th day prior to such annual meeting and not later than 5:00 p.m., Pacific time, on the later of (i) the 90th day prior to such annual meeting, or (ii) the 10th day following the day on which Public Announcement (as defined below) of the date of such annual meeting is first made. In no event shall any adjournment, rescheduling, postponement or other delay of an annual meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described in this Section 2.4(i)(a). “Public Announcement” shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or a comparable national news service, in a document publicly filed by the corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d) of the 1934 Act or by such other means as is reasonably designed to inform the public or stockholders of the corporation in general of such information, including, without limitation, posting on the corporation’s investor relations website.

(b)    To be in proper written form, a stockholder’s notice to the Secretary must set forth as to each matter of business the stockholder intends to bring before the annual meeting:

-2-

(1)    a brief description of the business intended to be brought before the annual meeting and the reasons for conducting such business at the annual meeting,

(2)    the text of the proposed business (including the text of any resolutions proposed for consideration and, in the event that such business includes a proposal to amend the bylaws of the corporation, the text of the proposed amendment),

(3)    any agreement, arrangement or understanding between or among the stockholder or any Stockholder Associated Person (as defined below) and any other person or persons (including, in each case, their names) in connection with the proposal of such business,

(4)    the name and address, as they appear on the corporation’s books, of the stockholder and any Stockholder Associated Person,

(5)    the class or series and number of shares of the corporation that are, directly or indirectly, held of record or are beneficially owned (within the meaning of Rule 13d-3 under the 1934 Act) by the stockholder or any Stockholder Associated Person and any derivative positions held or beneficially held by the stockholder or any Stockholder Associated Person,

(6)    any proportionate interest in the corporation’s securities or any Derivative Instruments (as defined below) held, directly or indirectly, by a general or limited partnership in which the stockholder or any Stockholder Associated Person is a general partner or, directly or indirectly, beneficially owns an interest in a general partner of such general or limited partnership,

(7)    any (i) agreement, arrangement or understanding (including, without limitation and regardless of the form of settlement, any derivative, long or short positions, profit interests, forwards, futures, swaps, options, warrants, convertible securities, stock appreciation or similar rights, hedging or other transaction or series of transactions and borrowed or loaned shares) that has been entered into by or on behalf of the stockholder or any Stockholder Associated Person with respect to any securities of the corporation (any of the foregoing, a “Derivative Instrument”) including the full notional amount of any securities that, directly or indirectly, underlie any Derivative Instrument, and (ii) other agreement, arrangement or understanding, the effect or intent of which is to create or mitigate loss to, or to manage the risk or benefit from share price changes for, or to increase or decrease the voting power of, the stockholder or any Stockholder Associated Person with respect to any securities of the corporation,

(8)    any rights to dividends on the corporation’s securities owned beneficially by the stockholder or any Stockholder Associated Person that are separated or separable from the underlying security,

(9)    any material equity interests or any Derivative Instruments in any principal competitor of the corporation that are held by the stockholder or any Stockholder Associated Person,

(10)    any material interest of the stockholder or a Stockholder Associated Person in such business,

(11)    any material pending or threatened legal proceeding in which the stockholder or any Stockholder Associated Person is a party or material participant involving the corporation or any of its officers or directors, or any affiliate of the corporation,

(12)    any other material relationship between such stockholder or any Stockholder Associated Person, on the one hand, and (x) the corporation or any of its officers, directors or affiliates or (y) any principal competitor of the corporation, on the other hand,

-3-

(13)    any direct or indirect interest of the stockholder or any Stockholder Associated Person in any contract or agreement with the corporation, any affiliate of the corporation or any principal competitor of the corporation (including, in any such case, without limitation, any employment agreement, collective bargaining agreement or consulting agreement),

(14)    a representation and undertaking as to whether the stockholder or any Stockholder Associated Person or others acting in concert with them intends, or is part of a group that intends, to (x) deliver a proxy statement or form of proxy to or otherwise solicit proxies from holders of at least the percentage of the voting power of the corporation’s then-outstanding stock required to approve or adopt the proposal or (y) otherwise solicit proxies from stockholders in support of such proposal,

(15) any performance-related fees (other than an asset-based fee) that the stockholder or any Stockholder Associated Person is entitled to based on any increase or decrease in the value of the corporation’s securities or any Derivative Instruments, including, without limitation, any such interests held by members of the immediate family of such persons sharing the same household,

(16) any proxy, contract, arrangement, understanding or relationship pursuant to which the stockholder or any Stockholder Associated Person has a right to vote any shares of any security of the corporation,

(17)    any other information relating to the stockholder or any Stockholder Associated Person or others acting in concert with them, or relating to the proposal or item of business, that, in each case, (x) would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies or consents in support of the business proposed to be brought before the meeting pursuant to Section 14 of the 1934 Act and (y) may reasonably be required to determine whether such proposed item of business is a proper matter for stockholder action, and

(18) a representation and undertaking that the stockholder is a holder of record of stock of the corporation as of the date of submission of the stockholder’s notice and intends to appear in person or by proxy at the annual meeting to bring such business before the annual meeting (such information provided and such representations and undertakings made as required by clauses (1) through (18), a “Business Solicitation Statement”).

In addition, to be in proper written form and timely, a stockholder’s notice (and any additional information submitted to the corporation in connection therewith) to the Secretary must be updated and supplemented (A) if necessary, so that the information provided or required to be provided in such notice is true and correct as of the record date(s) for determining the stockholders entitled to notice of, and to vote at, the annual meeting and as of the date that is 10 business days prior to the annual meeting or any adjournment, rescheduling, postponement or other delay thereof, and (B) to provide any additional information that the corporation may reasonably request. Such update and supplement or additional information must be received by the Secretary at the principal executive offices of the corporation, in the case of a request for additional information, promptly following a request therefor, which response must be received by the Secretary not later than such reasonable time as is specified in any such request from the corporation or, in the case of any other update or supplement of any information, not later than five business days after the record date(s) for the annual meeting (in the case of any update and supplement required to be made as of the record date(s)), and not later than eight business days prior to the date of the annual meeting or any adjournment, rescheduling, postponement or other delay thereof (in the case of any update or supplement required to be made as of 10 business days prior to the annual meeting or any adjournment, rescheduling, postponement or other delay thereof). The failure to timely provide such update, supplement or additional information shall result in the proposal no longer being eligible for consideration at the annual meeting. For purposes of this Section 2.4, a “Stockholder Associated Person” of any stockholder shall mean (i) any person controlling, directly or indirectly, or acting in concert with, such stockholder, (ii) any beneficial owner of shares of stock of the corporation owned of record or beneficially by such stockholder and on whose behalf the proposal or nomination, as the case may be, is being made, (iii) any person controlling, controlled by or under common control with such person referred to in the preceding clauses (i) and (ii).

-4-

(c)    Without exception, no business shall be conducted at any annual meeting except in accordance with the provisions set forth in this Section 2.4. In addition, business proposed to be brought by a stockholder may not be brought before the annual meeting if such stockholder or a Stockholder Associated Person, as applicable, takes action contrary to the representations made in the Business Solicitation Statement applicable to such business or if the Business Solicitation Statement applicable to such business contains an untrue statement of a material fact or omits to state a material fact necessary to make the statements therein not misleading. The chairperson of the annual meeting shall, if the facts warrant, determine and declare at the annual meeting that business was not properly brought before the annual meeting and in accordance with the provisions of this Section 2.4, and, if the chairperson should so determine, the chairperson shall so declare at the annual meeting that any such business not properly brought before the annual meeting shall not be conducted.

(ii)    Advance Notice of Director Nominations at Annual Meetings. Notwithstanding anything in these bylaws to the contrary, only persons who are nominated in accordance with the procedures set forth in this Section 2.4 shall be eligible for election or re-election as directors at an annual meeting of stockholders. Nominations of persons for election or re-election to the board of directors shall be made at an annual meeting of stockholders only (A) by or at the direction of the board of directors, or any committee thereof that has been formally delegated authority to nominate such persons pursuant to a resolution adopted by the affirmative vote of a majority of the Whole Board, (B) by a stockholder of the corporation who (1) is a stockholder of record at the time of the giving of the notice required by this Section 2.4(ii), (2) is a stockholder of record on the record date for the determination of stockholders entitled to notice of the annual meeting, (3) is a stockholder of record on the record date for the determination of stockholders entitled to vote at the annual meeting, (4) is a stockholder of record at the time of the annual meeting, and (5) has complied with the notice procedures set forth in this Section 2.4, or (C) as may be provided in the certificate of designations for any series of Preferred Stock. In addition to any other applicable requirements, for a nomination to be made by a stockholder, the stockholder must have given timely notice thereof in proper written form to the Secretary at the principal executive offices of the corporation.

(a)    To comply with clause (B) of Section 2.4(ii) above, a nomination to be made by a stockholder must set forth all information required under this Section 2.4(ii) and must be received by the Secretary at the principal executive offices of the corporation at the time set forth in, and in accordance with, the second sentence of Section 2.4(i)(a) above. In no event may a stockholder provide notice with respect to a greater number of director candidates than there are director seats subject to election by stockholders at the annual meeting. If the number of directors to be elected to the board of directors is increased and there is no Public Announcement naming all of the nominees for director or specifying the size of the increased board of directors at least 10 days before the last day a stockholder may deliver a notice of nomination pursuant to the foregoing provisions, then a stockholder’s notice required by this Section 2.4(ii) shall also be considered timely, but only with respect to any nominees for any new positions created by such increase, if it shall be received by the Secretary at the principal executive offices of the corporation not later than 5:00 p.m., Pacific time, on the 10th day following the day on which such Public Announcement is first made.

(b)    To be in proper written form, such stockholder’s notice to the Secretary must set forth:

(1)    as to each person whom the stockholder proposes to nominate for election or re-election as a director (a “nominee”): (A) the name, age, business address and residence address of the nominee, (B) the principal occupation or employment of the nominee, (C) the class and number of shares of the corporation that are held of record or are beneficially owned by the nominee and any Derivative Instruments held or beneficially held by the nominee, including the full notional amount of any securities that, directly or indirectly, underlie any such Derivative Instrument, (D) any other agreement, arrangement or understanding that has been made the effect or intent of which is to create or mitigate loss to, or to manage the risk or benefit of share price changes for, or to increase or decrease the voting power of the nominee with respect to the corporation’s securities, (E) any direct or indirect compensatory, payment, indemnification or other financial agreement, arrangement or understanding that such nominee has, or has had within the past three years, with any person or entity other than the corporation (including, without limitation, the amount of

-5-

any payment or payments received or receivable thereunder), in each case in connection with candidacy or service as a director of the corporation (such agreement, arrangement or understanding, a “Third-Party Compensation Arrangement”), (F) a description of any other material relationships between the nominee and such nominee’s respective affiliates and associates, or others acting in concert with them, on the one hand, and such stockholder giving the notice and any Stockholder Associated Person, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such stockholder or Stockholder Associated Person were the “registrant” for the purposes of such rule and such nominee were a director or executive officer of such registrant, (G) a written statement executed by the nominee consenting to (x) being named as a nominee of such stockholder, (y) serving as a director of the corporation if elected and (z) being named in the corporation’s form of proxy pursuant to Rule 14a-19 under the 1934 Act (“Rule 14a-19”), and (H) any other information relating to the nominee that would be required to be disclosed about such nominee if proxies were being solicited for the election or re-election of the nominee as a director, or that is otherwise required, in each case pursuant to Section 14 of the 1934 Act; and

(2)    as to such stockholder giving notice, (A) the information required to be provided pursuant to clauses (2) through (13) and (15) through (18) of Section 2.4(i)(b) above, and the update and supplement referenced in Section 2.4(i)(b) above (except that the references to “business” in such clauses shall instead refer to nominations of directors for purposes of this paragraph), with such update and supplement being subject to the terms of the second and third sentences of Section 2.4(i)(b), and (B) a representation and undertaking as to whether such stockholder or Stockholder Associated Person or others acting in concert with them intends, or is part of a group that intends, to (x) deliver a proxy statement or form of proxy to or otherwise solicit proxies from holders of at least the percentage of the voting power of the corporation’s then-outstanding stock required to elect or re-elect such nominee(s) (which representation and undertaking must include a statement as to whether such stockholder or any Stockholder Associated Person intends to solicit the requisite percentage of the voting power of the corporation’s stock under Rule 14a-19), or (y) otherwise solicit proxies from stockholders in support of such nomination (such information provided and statements made as required by Section 2.4(ii)(b)(1) and this Section 2.4(ii)(b)(2), a “Nominee Solicitation Statement”).

(c)    To be eligible to be a nominee of any stockholder for election or re-election as a director of the corporation, any person nominated by a stockholder for election or re-election as a director must, at the request of the board of directors furnish to the Secretary (1) that information required to be set forth in the stockholder’s notice of nomination of such person as a director as of a date subsequent to the date on which the notice of such person’s nomination was given, (2) such other information as may reasonably be required by the corporation to determine the eligibility of such proposed nominee to serve as an independent director or audit committee financial expert of the corporation under applicable law, securities exchange rule or regulation, or any publicly-disclosed corporate governance guideline or committee charter of the corporation and (3) such other information that could be material to a reasonable stockholder’s understanding of the independence, or lack thereof, or the qualifications of such nominee. Such additional information, if applicable, must be received by the Secretary at the principal executive offices of the corporation promptly following a request therefor, not later than such reasonable time as is specified in any such request from the corporation. In the absence of the timely furnishing of such information, if requested, such stockholder’s nomination shall not be considered in proper form and shall be ineligible for consideration at the annual meeting pursuant to this Section 2.4(ii).

(d)    Without exception, no person shall be eligible for election or re-election as a director of the corporation at an annual meeting of stockholders unless nominated in accordance with the provisions set forth in this Section 2.4. No later than five business days prior to the annual meeting or any adjournment, rescheduling, postponement or other delay thereof, a stockholder nominating individuals for election or re-election as a director will provide the corporation with reasonable evidence that such stockholder has met the requirements of Rule 14a-19. The failure to timely provide such update, supplement, evidence or additional information shall result in such nominee(s) no longer being eligible for consideration at the annual meeting. If the stockholder fails to comply with the requirements of Rule 14a-19 (including because the stockholder fails to provide the corporation with all information or notices required by Rule

-6-

14a-19), then the director nominee(s) proposed by such stockholder shall be ineligible for election or re-election at the annual meeting, and any votes or proxies in respect of such nomination shall be disregarded, notwithstanding that such proxies may have been received by the corporation and counted for the purposes of determining quorum. In addition, a nominee shall not be eligible for election or re-election if a stockholder or Stockholder Associated Person, as applicable, takes action contrary to the representations made in the Nominee Solicitation Statement applicable to such nominee or in any other notice to the corporation or if the Nominee Solicitation Statement applicable to such nominee or any other information provided to the corporation by or on behalf of such nominee contains an untrue statement of a material fact or omits to state a material fact necessary to make the statements therein not misleading. The chairperson of the annual meeting shall, if the facts warrant, determine and declare at the annual meeting that a nomination was not made in accordance with the provisions prescribed by these bylaws, and if the chairperson should so determine, the chairperson shall so declare at the annual meeting, and the defective nomination shall be disregarded.

(iii)    Advance Notice of Director Nominations for Special Meetings.

(a)    For a special meeting of stockholders at which directors are to be elected or re-elected, nominations of persons for election or re-election to the board of directors shall be made only (1) by or at the direction of the board of directors, or any committee thereof that has been formally delegated authority to nominate such persons pursuant to a resolution adopted by the affirmative vote of a majority of the Whole Board, or (2) by any stockholder of the corporation who (A) is a stockholder of record at the time of the giving of the notice required by this Section 2.4(iii), (B) is a stockholder of record on the record date for the determination of stockholders entitled to notice of the special meeting, (C) is a stockholder of record on the record date for the determination of stockholders entitled to vote at the special meeting, (D) is a stockholder of record at the time of the special meeting and (E) delivers a timely written notice of the nomination to the Secretary that includes the information set forth in Sections 2.4(ii)(b) and (ii)(c) above (with references therein to “annual meeting” deemed to mean “special meeting” for the purposes of this Section 2.4(iii)). To be timely, such notice must be received by the Secretary at the principal executive offices of the corporation not earlier than 8:00 a.m., Pacific time, on the 120th day prior to the day of the special meeting and not later than 5:00 p.m., Pacific time, on the later of (i) the 90th day prior to such special meeting or (ii) the 10th day following the day on which Public Announcement is first made of the date of the special meeting and of the nominees proposed by the board of directors to be elected or re-elected at such special meeting. In no event shall any adjournment, rescheduling or postponement of a special meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above. A person shall not be eligible for election or re-election as a director at a special meeting unless the person is nominated (i) by or at the direction of the board of directors or any committee thereof that has been formally delegated authority to nominate any such persons pursuant to a resolution adopted by the affirmative vote of a majority of the Whole Board or (ii) by a stockholder in accordance with the notice procedures set forth in this Section 2.4(iii). In addition, a nominee shall not be eligible for election or re-election if a stockholder or Stockholder Associated Person, as applicable, takes action contrary to the representations made in the Nominee Solicitation Statement applicable to such nominee or in any other notice to the corporation or if the Nominee Solicitation Statement applicable to such nominee or any other information provided to the corporation by or on behalf of such nominee contains an untrue statement of a material fact or omits to state a material fact necessary to make the statements therein not misleading. Any person nominated in accordance with this Section 2.4(iii) is subject to, and must comply with, the provisions of Section 2.4(ii)(c).

(b)    The chairperson of the special meeting shall, if the facts warrant, determine and declare at the meeting that a nomination or business was not made in accordance with the procedures prescribed by these bylaws, and if the chairperson should so determine, the chairperson shall so declare at the meeting, and the defective nomination or business shall be disregarded.

(iv)    Other Requirements and Procedures.

(a)    In addition to the foregoing provisions of this Section 2.4, a stockholder must also comply with all applicable requirements of state law and of the 1934 Act and the rules and regulations

-7-

thereunder with respect to the matters set forth in this Section 2.4. Nothing in this Section 2.4 shall be deemed to affect any rights of: (1) a stockholder to request the inclusion of proposals in the corporation’s proxy statement pursuant to Rule 14a-8 (or any successor provision) under the 1934 Act or (2) the corporation to omit a proposal from the corporation’s proxy statement pursuant to Rule 14a-8 (or any successor provision) under the 1934 Act.

(b)    To be eligible to be a nominee of any stockholder for election or re-election as a director of the corporation, the proposed nominee must provide to the Secretary, in accordance with the applicable time periods prescribed for delivery of notice under Section 2.4(ii)(a) or Section 2.4(iii): (1) a signed and completed written questionnaire (in the form provided by the Secretary at the written request of the nominating stockholder, which form will be provided by the Secretary within 10 days of receiving such request) containing information regarding such nominee’s background and qualifications and such other information as may reasonably be required by the corporation to determine the eligibility of such nominee to serve as a director of the corporation or to serve as an independent director of the corporation; (2) a written representation and undertaking that, unless previously disclosed to the corporation, such nominee is not, and will not become, a party to any voting agreement, arrangement, commitment, assurance or understanding with any person or entity as to how such nominee, if elected as a director, will vote on any issue; (3) a written representation and undertaking that, unless previously disclosed to the corporation, such nominee is not, and will not become, a party to any Third-Party Compensation Arrangement; (4) a written representation and undertaking that, if elected as a director, such nominee would be in compliance, and will continue to comply, with the corporation’s corporate governance, conflict of interest, confidentiality, stock ownership and trading guidelines, and other policies and guidelines applicable to directors and in effect during such person’s term in office as a director (and, if requested by any candidate for nomination, the Secretary will provide to such proposed nominee all such policies and guidelines then in effect); and (5) a written representation and undertaking that such nominee, if elected, intends to serve a full term on the board of directors.

(c)    At the request of the board of directors, any person nominated by the board of directors for election or re-election as a director must furnish to the Secretary the information that is required to be set forth in a stockholder’s notice of nomination pertaining to such nominee.

(d)    For the avoidance of doubt, the obligation to update and supplement, or provide additional information or evidence, as set forth in these bylaws shall not limit the corporation’s rights with respect to any deficiencies in any notice provided by a stockholder, extend any applicable deadlines pursuant to these bylaws or enable or be deemed to permit a stockholder who has previously submitted notice pursuant to these bylaws to amend or update any nomination or to submit any new nomination. No disclosure pursuant to these bylaws will be required with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is the stockholder submitting a notice pursuant to this Section 2.4 solely because such broker, dealer, commercial bank, trust company or other nominee has been directed to prepare and submit the notice required by these bylaws on behalf of a beneficial owner.

(e)    Notwithstanding anything to the contrary in this Section 2.4, unless otherwise required by law, if the stockholder (or a qualified representative of the stockholder) does not appear in person at the applicable meeting to present a nomination or other proposed business, such nomination will be disregarded or such proposed business will not be transacted, as the case may be, notwithstanding that proxies in respect of such nomination or business may have been received by the corporation and counted for purposes of determining a quorum. For purposes of this Section 2.4, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the applicable meeting, and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the applicable meeting.

-8-

2.5    NOTICE OF STOCKHOLDERS’ MEETINGS

Whenever stockholders are required or permitted to take any action at a meeting, a notice of the meeting shall be given which shall state the place, if any, date and hour of the meeting, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. Except as otherwise provided in the DGCL, the certificate of incorporation or these bylaws, the notice of any meeting of stockholders shall be given not less than 10 nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting.

2.6    QUORUM

The holders of a majority of the voting power of the capital stock of the corporation issued and outstanding and entitled to vote, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders, unless otherwise required by law, the certificate of incorporation, these bylaws or the rules of any applicable stock exchange. Where a separate vote by a class or series or classes or series is required, a majority of the voting power of the outstanding shares of such class or series or classes or series, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter, except as otherwise required by law, the certificate of incorporation, these bylaws or the rules of any applicable stock exchange.

If a quorum is not present or represented at any meeting of stockholders, then either (i) the chairperson of the meeting, or (ii) the stockholders entitled to vote at the meeting, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present or represented. At such adjourned meeting at which a quorum is present or represented, any business may be transacted that might have been transacted at the original meeting.

2.7    ADJOURNED MEETING; NOTICE

Unless these bylaws otherwise require, when a meeting is adjourned to another time or place (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication), notice need not be given of the adjourned meeting if the time, place, if any, thereof, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are (i) announced at the meeting at which the adjournment is taken, (ii) displayed, during the time scheduled for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication or (iii) set forth in the notice of meeting given in accordance with Section 222(a) of the DGCL. At the adjourned meeting, the corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than 30 days, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment a new record date for stockholders entitled to vote is fixed for the adjourned meeting, the board of directors shall fix a new record date for notice of such adjourned meeting in accordance with Section 213(a) of the DGCL and Section 2.11 of these bylaws, and shall give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of the record date fixed for notice of such adjourned meeting.

2.8    CONDUCT OF BUSINESS

The chairperson of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including such regulation of the manner of voting and the conduct of business and discussion as seem to the chairperson in order. The chairperson of any meeting of stockholders shall be

-9-

designated by the board of directors; in the absence of such designation, the chairperson of the board of directors, if any, the chief executive officer (in the absence of the chairperson) or the president (in the absence of the chairperson of the board of directors and the chief executive officer), or in their absence any other executive officer of the corporation, shall serve as chairperson of the stockholder meeting. The chairperson of any stockholder meeting shall have the power to adjourn the meeting to another place, if any, date or time, whether or not a quorum is present.

2.9    VOTING

The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section 2.11 of these bylaws, subject to Section 217 (relating to voting rights of fiduciaries, pledgors and joint owners of stock) and Section 218 (relating to voting trusts and other voting agreements) of the DGCL.

Except as may be otherwise provided in the certificate of incorporation or these bylaws, each stockholder shall be entitled to one vote for each share of capital stock held by such stockholder as of the applicable record date that has voting power upon the matter in question.

Except as otherwise provided by law, the certificate of incorporation, these bylaws or the rules of any applicable stock exchange, in all matters other than the election of directors, the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter shall be the act of the stockholders. Except as otherwise required by law, the certificate of incorporation or these bylaws, directors shall be elected by a plurality of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. Where a separate vote by a class or series or classes or series is required, in all matters other than the election of directors, the affirmative vote of the majority of the voting power of the shares of such class or series or classes or series present in person or represented by proxy at the meeting and entitled to vote on the subject matter shall be the act of such class or series or classes or series, except as otherwise provided by law, the certificate of incorporation, these bylaws or the rules of any applicable stock exchange.

2.10    STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING

Subject to the rights of the holders of the shares of any series of Preferred Stock, any action required or permitted to be taken by the stockholders of the corporation must be effected at a duly called annual or special meeting of stockholders of the corporation and may not be effected by any consent in writing by such stockholders.

2.11    RECORD DATES

In order that the corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment thereof, the board of directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the board of directors and which record date shall not be more than 60 nor less than 10 days before the date of such meeting. If the board of directors so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the board of directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination.

If no record date is fixed by the board of directors, the record date for determining stockholders entitled to notice of and to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.

A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the board of directors may fix a new

-10-

record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the provisions of Section 213 of the DGCL and this Section 2.11 at the adjourned meeting.

In order that the corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the board of directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the board of directors adopts the resolution relating thereto.

2.12    PROXIES

Each stockholder entitled to vote at a meeting of stockholders, or such stockholder’s authorized director, officer, employee or agent, may authorize another person or persons to act for such stockholder by proxy authorized by a document or by a transmission permitted by law filed in accordance with the procedure established for the meeting, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. The authorization of a person to act as a proxy may be documented, signed and delivered in accordance with Section 116 of the DGCL; provided that such authorization shall set forth, or be delivered with information enabling the corporation to determine, the identity of the stockholder granting such authorization. The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section 212 of the DGCL.

2.13    LIST OF STOCKHOLDERS ENTITLED TO VOTE

The corporation shall prepare, no later than the 10th day before each meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting; provided, however, if the record date for determining the stockholders entitled to vote is less than 10 days before the meeting date, the list shall reflect the stockholders entitled to vote as of the 10th day before the meeting date, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. The corporation shall not be required to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder for any purpose germane to the meeting for a period of 10 days ending on the day before the meeting date: (i) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii) during ordinary business hours, at the corporation’s principal place of business. If the corporation determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available only to stockholders of the corporation.

2.14    INSPECTORS OF ELECTION

Before any meeting of stockholders, the corporation shall appoint one or more inspectors of election to act at the meeting or its adjournment and make a written report thereof. The corporation may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the chairperson of the meeting shall appoint one or more inspectors to act at the meeting.

Each inspector, before entering upon the discharge of the duties of inspector, shall take and sign an oath to execute faithfully the duties of inspector with strict impartiality and according to the best of such inspector’s ability. Such inspectors shall take all actions as contemplated under Section 231 of the DGCL.

The inspectors of election shall perform their duties impartially, in good faith, to the best of their ability and as expeditiously as is practical. If there are multiple inspectors of election, the decision, act or

-11-

certificate of a majority is effective in all respects as the decision, act or certificate of all. Any report or certificate made by the inspectors of election is prima facie evidence of the facts stated therein.

ARTICLE III - DIRECTORS

3.1    POWERS

The business and affairs of the corporation shall be managed by or under the direction of the board of directors, except as may be otherwise provided in the DGCL or the certificate of incorporation.

3.2    NUMBER OF DIRECTORS

The board of directors shall consist of one or more members, each of whom shall be a natural person. Unless the certificate of incorporation fixes the number of directors and subject to the rights of holders of any series of Preferred Stock with respect to the election of directors, the number of directors shall be determined from time to time by resolution of the board of directors. No reduction of the authorized number of directors shall have the effect of removing any director before that director’s term of office expires.

3.3    ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS

Except as provided in Section 3.4 of these bylaws, each director, including a director elected to fill a vacancy or newly created directorship, shall hold office until the expiration of the term for which elected and until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal. Directors need not be stockholders unless so required by the certificate of incorporation or these bylaws. The certificate of incorporation or these bylaws may prescribe other qualifications for directors.

If so provided in the certificate of incorporation, the directors of the corporation shall be divided into three classes.

3.4    RESIGNATION AND VACANCIES

Any director may resign at any time upon notice given in writing or by electronic transmission to the corporation. A resignation is effective when the resignation is delivered unless the resignation specifies a later effective date or an effective date determined upon the happening of an event or events. Unless otherwise specified in the notice of resignation, acceptance of such resignation shall not be necessary to make it effective. A resignation which is conditioned upon the director failing to receive a specified vote for reelection as a director may provide that it is irrevocable. Unless otherwise provided in the certificate of incorporation or these bylaws, when one or more directors resign from the board of directors, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective.

Unless otherwise provided in the certificate of incorporation or these bylaws or permitted in the specific case by resolution of the board of directors, and subject to the rights (if any) of holders of Preferred Stock, vacancies and newly created directorships resulting from any increase in the authorized number of directors elected by all of the stockholders having the right to vote as a single class shall be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director, and not by stockholders. If the directors are divided into classes, a person so chosen to fill a vacancy or newly created directorship shall hold office until the next election of the class for which such director shall have been chosen and until his or her successor shall have been duly elected and qualified.

-12-

3.5    PLACE OF MEETINGS; MEETINGS BY TELEPHONE

The board of directors may hold meetings, both regular and special, either within or outside the State of Delaware.

Unless otherwise restricted by the certificate of incorporation or these bylaws, members of the board of directors, or any committee designated by the board of directors or any subcommittee, may participate in a meeting of the board of directors, or any such committee or subcommittee, by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting.

3.6    REGULAR MEETINGS

Regular meetings of the board of directors may be held without notice at such time and at such place as shall from time to time be determined by the board of directors.

3.7    SPECIAL MEETINGS; NOTICE

Special meetings of the board of directors for any purpose or purposes may be called at any time by the chairperson of the board of directors, the chief executive officer, the president, the Secretary or a majority of the Whole Board, at such times and places as such person or persons shall designate; provided, that the person(s) authorized to call special meetings of the board of directors may authorize another person or persons to send notice of such meeting.

Notice of the time and place of special meetings shall be:

(i)    delivered personally by hand, by courier or by telephone;

(ii)    sent by United States first-class mail, postage prepaid;

(iii)    sent by facsimile;

(iv)    sent by electronic mail; or

(v)    otherwise given by electronic transmission (as defined in Section 232 of the DGCL),

directed to each director at that director’s address, telephone number, facsimile number, electronic mail address or other contact for notice by electronic transmission, as the case may be, as shown on the corporation’s records.

If the notice is (i) delivered personally by hand, by courier or by telephone, (ii) sent by facsimile, (iii) sent by electronic mail or (iv) otherwise given by electronic transmission, it shall be delivered, sent or otherwise directed to each director, as applicable, at least 24 hours before the time of the holding of the meeting. If the notice is sent by United States mail, it shall be deposited in the United States mail at least four days before the time of the holding of the meeting. Any oral notice of the time and place of the meeting may be communicated to the director in lieu of written notice if such notice is communicated at least 24 hours before the time of the holding of the meeting. The notice need not specify the place of the meeting (if the meeting is to be held at the corporation’s principal executive office) nor the purpose of the meeting, unless required by statute.

-13-

3.8    QUORUM; VOTING

At all meetings of the board of directors, a majority of the Whole Board shall constitute a quorum for the transaction of business. If a quorum is not present at any meeting of the board of directors, then the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present.

The affirmative vote of a majority of the directors present at any meeting at which a quorum is present shall be the act of the board of directors, except as may be otherwise specifically provided by statute, the certificate of incorporation or these bylaws.

If the certificate of incorporation provides that one or more directors shall have more or less than one vote per director on any matter, every reference in these bylaws to a majority or other proportion of the directors shall refer to a majority or other proportion of the votes of the directors.

3.9    BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING

Unless otherwise restricted by the certificate of incorporation or these bylaws, (i) any action required or permitted to be taken at any meeting of the board of directors, or of any committee or subcommittee thereof, may be taken without a meeting if all members of the board of directors or committee, or subcommittee, as the case may be, consent thereto in writing or by electronic transmission and (ii) a consent may be documented, signed and delivered in any manner permitted by Section 116 of the DGCL. Any person (whether or not then a director) may provide, whether through instruction to an agent or otherwise, that a consent to action will be effective at a future time (including a time determined upon the happening of an event), no later than 60 days after such instruction is given or such provision is made and such consent shall be deemed to have been given for purposes of this Section 3.9 at such effective time so long as such person is then a director and did not revoke the consent prior to such time. Any such consent shall be revocable prior to its becoming effective. After an action is taken, the consent or consents relating thereto shall be filed with the minutes of the proceedings of the board of directors, or the committee or subcommittee thereof, in the same paper or electronic form as the minutes are maintained.

3.10    FEES AND COMPENSATION OF DIRECTORS

Unless otherwise restricted by the certificate of incorporation or these bylaws, the board of directors shall have the authority to fix the compensation of directors.

3.11    REMOVAL OF DIRECTORS

Unless otherwise provided in the certificate of incorporation, any director may be removed from office by the stockholders of the corporation in the manner specified in the certificate of incorporation and applicable law.

No reduction of the authorized number of directors shall have the effect of removing any director prior to the expiration of such director’s term of office.

ARTICLE IV - COMMITTEES

4.1    COMMITTEES OF DIRECTORS

The board of directors may, by resolution adopted by the affirmative vote of a majority of the Whole Board, designate one or more committees, each committee to consist of one or more of the directors of the corporation. The board of directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the

-14-

absence or disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the board of directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the board of directors or in these bylaws, shall have and may exercise all the powers and authority of the board of directors in the management of the business and affairs of the corporation, and may authorize the seal of the corporation to be affixed to all papers that may require it; but no such committee shall have the power or authority to (i) approve or adopt, or recommend to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to stockholders for approval, or (ii) adopt, amend or repeal any bylaw of the corporation.

4.2    COMMITTEE MINUTES

Each committee and subcommittee shall keep regular minutes of its meetings.

4.3    MEETINGS AND ACTION OF COMMITTEES

Unless otherwise specified by the board of directors, meetings and actions of committees and subcommittees shall be governed by, and held and taken in accordance with, the provisions of:

(i)    Section 3.5 (place of meetings and meetings by telephone);

(ii)    Section 3.6 (regular meetings);

(iii)    Section 3.7 (special meetings and notice);

(iv)    Section 3.8 (quorum; voting);

(v)    Section 7.4 (waiver of notice); and

(vi)    Section 3.9 (action without a meeting)

with such changes in the context of those bylaws as are necessary to substitute the committee or subcommittee and its members for the board of directors and its members. However:

(i)    the time and place of regular meetings of committees or subcommittees may be determined either by resolution of the board of directors or by resolution of the committee or subcommittee;

(ii)    special meetings of committees or subcommittees may also be called by resolution of the board of directors or the committee or subcommittee; and

(iii)    notice of special meetings of committees and subcommittees shall also be given to all alternate members, who shall have the right to attend all meetings of the committee or subcommittee. The board of directors or a committee or subcommittee may also adopt other rules for the government of any committee or subcommittee.

Any provision in the certificate of incorporation providing that one or more directors shall have more or less than one vote per director on any matter shall apply to voting in any committee or subcommittee, unless otherwise provided in the certificate of incorporation or these bylaws.

4.4    SUBCOMMITTEES

Unless otherwise provided in the certificate of incorporation, these bylaws or the resolutions of the board of directors designating the committee, a committee may create one or more subcommittees, each

-15-

subcommittee to consist of one or more members of the committee, and delegate to a subcommittee any or all of the powers and authority of the committee.

ARTICLE V - OFFICERS

5.1    OFFICERS

The officers of the corporation shall be a president and a secretary. The corporation may also have, at the discretion of the board of directors, a chairperson of the board of directors, a vice chairperson of the board of directors, a chief executive officer, a chief financial officer or treasurer, one or more vice presidents, one or more assistant vice presidents, one or more assistant treasurers, one or more assistant secretaries, and any such other officers with such other titles as may be appointed from time to time in accordance with the provisions of these bylaws. Any number of offices may be held by the same person.

5.2    APPOINTMENT OF OFFICERS

The board of directors shall appoint the officers of the corporation, except such officers as may be appointed in accordance with the provisions of Section 5.3 of these bylaws, subject to the rights, if any, of an officer under any contract of employment.

5.3    SUBORDINATE OFFICERS

The board of directors, or any duly authorized committee or subcommittee thereof, may appoint, or empower any officer to appoint, such other officers as the business of the corporation may require. Each of such officers shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws or as the board of directors, any duly authorized committee or subcommittee thereof, or any officer who has been conferred such power of determination may from time to time determine.

5.4    REMOVAL AND RESIGNATION OF OFFICERS

Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by the board of directors or any duly authorized committee or subcommittee thereof or by any officer who has been conferred such power of removal.

Any officer may resign at any time by giving written or electronic notice to the corporation. Any resignation shall take effect at the date of the receipt of that notice or at any later time specified in that notice. Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the rights, if any, of the corporation under any contract to which the officer is a party.

5.5    VACANCIES IN OFFICES

Any vacancy occurring in any office of the corporation shall be filled by the board of directors or as provided in Section 5.3.

5.6    REPRESENTATION OF SECURITIES OF OTHER ENTITIES

The chairperson of the board of directors, the chief executive officer, the president, any vice president, the treasurer, the secretary or assistant secretary of this corporation, or any other person authorized by the board of directors or the chief executive officer, the president or a vice president, is authorized to vote, represent, and exercise on behalf of this corporation all rights incident to any and all shares or other securities of, or interests in, or issued by, any other entity or entities, and all rights incident to any management authority conferred on this corporation in accordance with the governing documents of any entity or entities,

-16-

standing in the name of this corporation, including the right to act by written consent. The authority granted herein may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed by such person having the authority.

5.7    AUTHORITY AND DUTIES OF OFFICERS

Each officer of the corporation shall have such authority and perform such duties in the management of the business of the corporation as may be designated from time to time by the board of directors or, for the avoidance of doubt, any duly authorized committee or subcommittee thereof or by any officer who has been conferred such power of designation and, to the extent not so provided, as generally pertain to such office, subject to the control of the board of directors.

ARTICLE VI - STOCK

6.1    STOCK CERTIFICATES; PARTLY PAID SHARES

The shares of the corporation shall be represented by certificates, provided that the board of directors may provide by resolution or resolutions that some or all of any or all classes or series of its stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the corporation. Unless otherwise provided by resolution of the board of directors, every holder of stock represented by certificates shall be entitled to have a certificate signed by, or in the name of, the corporation by any two officers of the corporation representing the number of shares registered in certificate form. Any or all of the signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the corporation with the same effect as if such person were such officer, transfer agent or registrar at the date of issue. The corporation shall not have power to issue a certificate in bearer form.

The corporation may issue the whole or any part of its shares as partly paid and subject to call for the remainder of the consideration to be paid therefor. Upon the face or back of each stock certificate issued to represent any such partly-paid shares, or upon the books and records of the corporation in the case of uncertificated partly-paid shares, the total amount of the consideration to be paid therefor and the amount paid thereon shall be stated. Upon the declaration of any dividend on fully-paid shares, the corporation shall declare a dividend upon partly-paid shares of the same class, but only upon the basis of the percentage of the consideration actually paid thereon.

6.2    SPECIAL DESIGNATION ON CERTIFICATES

If the corporation is authorized to issue more than one class of stock or more than one series of any class, then the powers, the designations, the preferences, and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights shall be set forth in full or summarized on the face or back of the certificate that the corporation shall issue to represent such class or series of stock; provided, however, that, except as otherwise provided in Section 202 of the DGCL, in lieu of the foregoing requirements there may be set forth on the face or back of the certificate that the corporation shall issue to represent such class or series of stock, a statement that the corporation will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights. Within a reasonable time after the issuance or transfer of uncertificated stock, the registered owner thereof shall be given a notice, in writing or by electronic transmission, containing the information required to be set forth or stated on certificates pursuant to this Section 6.2 or Sections 151, 156, 202(a), 218(a) or 364 of the DGCL or with respect to this Section 6.2 a statement that the corporation will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such

-17-

preferences and/or rights. Except as otherwise expressly provided by law, the rights and obligations of the holders of uncertificated stock and the rights and obligations of the holders of certificates representing stock of the same class and series shall be identical.

6.3    LOST CERTIFICATES

Except as provided in this Section 6.3, no new certificates for shares shall be issued to replace a previously issued certificate unless the latter is surrendered to the corporation and cancelled at the same time. The corporation may issue a new certificate of stock or uncertificated shares in the place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the corporation may require the owner of the lost, stolen or destroyed certificate, or such owner’s legal representative, to give the corporation a bond, in such sum as the corporation may direct sufficient to indemnify it against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares.

6.4    DIVIDENDS

The board of directors, subject to any restrictions contained in the certificate of incorporation or applicable law, may declare and pay dividends upon the shares of the corporation’s capital stock. Dividends may be paid in cash, in property, or in shares of the corporation’s capital stock, subject to the provisions of the certificate of incorporation.

The board of directors may set apart out of any of the funds of the corporation available for dividends a reserve or reserves for any proper purpose and may abolish any such reserve. Such purposes shall include but not be limited to equalizing dividends, repairing or maintaining any property of the corporation, and meeting contingencies.

6.5    TRANSFER OF STOCK

Transfers of record of shares of stock of the corporation shall be made only upon its books by the holders thereof, in person or by an attorney duly authorized, and, subject to Section 6.3 of these bylaws, if such stock is certificated, upon the surrender of a certificate or certificates for a like number of shares, properly endorsed or accompanied by proper evidence of succession, assignation or authority to transfer.

6.6    STOCK TRANSFER AGREEMENTS

The corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes or series of stock of the corporation to restrict the transfer of shares of stock of the corporation of any one or more classes or series owned by such stockholders in any manner not prohibited by the DGCL.

6.7    REGISTERED STOCKHOLDERS

The corporation:

(i)    shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends and notices and to vote as such owner; and

(ii)    shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.

-18-

ARTICLE VII - MANNER OF GIVING NOTICE AND WAIVER

7.1    NOTICE OF STOCKHOLDERS’ MEETINGS

Notice of any meeting of stockholders shall be given in the manner set forth in the DGCL.

7.2    NOTICE TO STOCKHOLDERS SHARING AN ADDRESS

Except as otherwise prohibited under the DGCL, without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders given by the corporation under the provisions of the DGCL, the certificate of incorporation or these bylaws shall be effective if given by a single written notice to stockholders who share an address if consented to by the stockholders at that address to whom such notice is given. Any such consent shall be revocable by the stockholder by written notice to the corporation. Any stockholder who fails to object in writing to the corporation, within 60 days of having been given written notice by the corporation of its intention to send the single notice, shall be deemed to have consented to receiving such single written notice. This Section 7.2 shall not apply to Sections 164, 296, 311, 312 or 324 of the DGCL.

7.3    NOTICE TO PERSON WITH WHOM COMMUNICATION IS UNLAWFUL

Whenever notice is required to be given, under the DGCL, the certificate of incorporation or these bylaws, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any action or meeting which shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. If the action taken by the corporation is such as to require the filing of a certificate under the DGCL, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such persons with whom communication is unlawful.

7.4    WAIVER OF NOTICE

Whenever notice is required to be given under any provision of the DGCL, the certificate of incorporation or these bylaws, a written waiver, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice or any waiver by electronic transmission unless so required by the certificate of incorporation or these bylaws.

ARTICLE VIII - INDEMNIFICATION

8.1    INDEMNIFICATION OF DIRECTORS AND OFFICERS IN THIRD PARTY PROCEEDINGS

Subject to the other provisions of this Article VIII, the corporation shall indemnify, to the fullest extent permitted by the DGCL, as now or hereinafter in effect, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a “Proceeding”) (other than an action by or in the right of the corporation) by reason of the fact that such person is or was a director or officer of the corporation, or is or was a director or officer of the corporation serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses

-19-

(including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such Proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person’s conduct was unlawful. The termination of any Proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that such person’s conduct was unlawful.

8.2    INDEMNIFICATION OF DIRECTORS AND OFFICERS IN ACTIONS BY OR IN THE RIGHT OF THE CORPORATION

Subject to the other provisions of this Article VIII, the corporation shall indemnify, to the fullest extent permitted by the DGCL, as now or hereinafter in effect, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed Proceeding by or in the right of the corporation to procure a judgment in its favor by reason of the fact that such person is or was a director or officer of the corporation, or is or was a director or officer of the corporation serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such Proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation; except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been finally adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.

8.3    SUCCESSFUL DEFENSE

To the extent that a present or former director or officer (for the purposes of this Section 8.3 only, as such term is defined in Section 145(c)(1) of the DGCL) of the corporation has been successful on the merits or otherwise in defense of any Proceeding described in Section 8.1 or Section 8.2, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith. The corporation may indemnify any other person who is not a present or former director or officer of the corporation against expenses (including attorneys’ fees) actually and reasonably incurred by such person to the extent such person has been successful on the merits or otherwise in defense of any Proceeding described in Section 8.1 or Section 8.2, or in defense of any claim, issue or matter therein.

8.4    INDEMNIFICATION OF OTHERS

Subject to the other provisions of this Article VIII, the corporation shall have power to advance expenses to and indemnify its employees and agents, or any other persons, to the extent not prohibited by the DGCL or other applicable law. The board of directors shall have the power to delegate to any person or persons identified in subsections (1) through (4) of Section 145(d) of the DGCL the determination of whether employees or agents shall be indemnified or receive an advancement of expenses.

8.5    ADVANCED PAYMENT OF EXPENSES

Expenses (including attorneys’ fees) actually and reasonably incurred by an officer or director of the corporation in defending any Proceeding shall be paid by the corporation in advance of the final disposition of such Proceeding upon receipt of a written request therefor (together with documentation reasonably evidencing such expenses) and an undertaking by or on behalf of the person to repay such amounts if it shall

-20-

ultimately be determined that the person is not entitled to be indemnified under this Article VIII or the DGCL. Such expenses (including attorneys’ fees) actually and reasonably incurred by former directors and officers or other employees and agents of the corporation or by persons serving at the request of the corporation as directors, officers, employees or agents of another corporation, partnership, joint venture, trust or other enterprise may be so paid upon such terms and conditions, if any, as the corporation deems appropriate. The right to advancement of expenses shall not apply to any Proceeding (or any part of any Proceeding) for which indemnity is excluded pursuant to these bylaws, but shall apply to any Proceeding (or any part of any Proceeding) referenced in Section 8.6(ii) or 8.6(iii) prior to a determination that the person is not entitled to be indemnified by the corporation.

8.6    LIMITATION ON INDEMNIFICATION

Subject to the requirements in Section 8.3 and the DGCL, the corporation shall not be obligated to indemnify any person pursuant to this Article VIII in connection with any Proceeding (or any part of any Proceeding):

(i)    for which payment has actually been made to or on behalf of such person under any statute, insurance policy, indemnity provision, vote or otherwise, except with respect to any excess beyond the amount paid;

(ii)    for an accounting or disgorgement of profits pursuant to Section 16(b) of the 1934 Act, or similar provisions of federal, state or local statutory law or common law, if such person is held liable therefor (including pursuant to any settlement arrangements);

(iii)    for any reimbursement of the corporation by such person of any bonus or other incentive-based or equity-based compensation or of any profits realized by such person from the sale of securities of the corporation, as required in each case under the 1934 Act (including any such reimbursements that arise from an accounting restatement of the corporation pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the corporation of profits arising from the purchase and sale by such person of securities in violation of Section 306 of the Sarbanes-Oxley Act), if such person is held liable therefor (including pursuant to any settlement arrangements);

(iv)    initiated by such person, including any Proceeding (or any part of any Proceeding) initiated by such person against the corporation or its directors, officers, employees, agents or other indemnitees, unless (a) the board of directors authorized the Proceeding (or the relevant part of the Proceeding) prior to its initiation, (b) the corporation provides the indemnification, in its sole discretion, pursuant to the powers vested in the corporation under applicable law, (c) otherwise required to be made under Section 8.7 or (d) otherwise required by applicable law; or

(v)    if prohibited by applicable law; provided, however, that if any provision or provisions of this Article VIII shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (1) the validity, legality and enforceability of the remaining provisions of this Article VIII (including, without limitation, each portion of any paragraph or clause containing any such provision held to be invalid, illegal or unenforceable, that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby; and (2) to the fullest extent possible, the provisions of this Article VIII (including, without limitation, each such portion of any paragraph or clause containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.

8.7    DETERMINATION; CLAIM

If a claim for indemnification or advancement of expenses under this Article VIII is not paid in full within 90 days after receipt by the corporation of the written request therefor, the claimant shall be entitled to an adjudication by a court of competent jurisdiction of such claimant’s entitlement to such indemnification or advancement of expenses. The corporation shall indemnify such person against any and all expenses that are

-21-

actually and reasonably incurred by such person in connection with any action for indemnification or advancement of expenses from the corporation under this Article VIII, to the extent such person is successful in such action, and to the extent not prohibited by law. In any such suit, the corporation shall, to the fullest extent not prohibited by law, have the burden of proving that the claimant is not entitled to the requested indemnification or advancement of expenses.

8.8    NON-EXCLUSIVITY OF RIGHTS

The indemnification and advancement of expenses provided by, or granted pursuant to, this Article VIII shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under the certificate of incorporation or any statute, bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person’s official capacity and as to action in another capacity while holding such office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees or agents respecting indemnification and advancement of expenses, to the fullest extent not prohibited by the DGCL or other applicable law.

8.9    INSURANCE

The corporation may purchase and maintain insurance to the fullest extent permitted by the DGCL on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the corporation would have the power to indemnify such person against such liability under the provisions of the DGCL.

8.10    SURVIVAL

The rights to indemnification and advancement of expenses conferred by this Article VIII shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.

8.11    EFFECT OF REPEAL OR MODIFICATION

A right to indemnification or to advancement of expenses arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to or repeal or elimination of the certificate of incorporation or these bylaws after the occurrence of the act or omission that is the subject of the Proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission explicitly authorizes such elimination or impairment after such action or omission has occurred.

8.12    CERTAIN DEFINITIONS

For purposes of this Article VIII, references to the “corporation” shall include, in addition to the resulting entity, any constituent entity (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent entity, or is or was serving at the request of such constituent entity as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Article VIII with respect to the resulting or surviving entity as such person would have with respect to such constituent entity if its separate existence had continued. For purposes of this Article VIII, references to “other enterprises” shall include employee benefit plans; references to “fines” shall include any excise taxes assessed on a person with respect to an employee

-22-

benefit plan; and references to “serving at the request of the corporation” shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the corporation” as referred to in this Article VIII.

ARTICLE IX - GENERAL MATTERS

9.1    EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS

Except as otherwise provided by law, the certificate of incorporation or these bylaws, the board of directors may authorize any officer or officers, or agent or agents, or employee or employees, to enter into any contract or execute any document or instrument in the name of and on behalf of the corporation; such authority may be general or confined to specific instances. Unless so authorized or ratified by the board of directors or within the agency power of an officer, agent or employee, no officer, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.

9.2    FISCAL YEAR

The fiscal year of the corporation shall be fixed by resolution of the board of directors and may be changed by the board of directors.

9.3    SEAL

The corporation may adopt a corporate seal, which shall be adopted and which may be altered by the board of directors. The corporation may use the corporate seal by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced.

9.4    CONSTRUCTION; DEFINITIONS

Unless the context requires otherwise, the general provisions, rules of construction, and definitions in the DGCL shall govern the construction of these bylaws. Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular, and the term “person” includes both a corporation, partnership, limited liability company, joint venture, trust or other enterprise and a natural person. Any reference in these bylaws to a section of the DGCL shall be deemed to refer to such section as amended from time to time and any successor provisions thereto.

9.5    FORUM

Unless the corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, stockholder, officer or other employee of the corporation to the corporation or the corporation’s stockholders, (iii) any action arising pursuant to any provision of the DGCL, the certificate of incorporation, or these bylaws (as either may be amended from time to time), or (iv) any action asserting a claim governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which such court determines that there is an indispensable party not subject to the jurisdiction of such court (and the indispensable party does not consent to the personal jurisdiction of such court within 10 days following such determination), which is

-23-

vested in the exclusive jurisdiction of a court or forum other than such court, or for which such court does not have subject matter jurisdiction.

Unless the corporation consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, against any person in connection with any offering of the corporation’s securities, including, without limitation and for the avoidance of doubt, any auditor, underwriter, expert, control person or other defendant.

Any person or entity purchasing, holding or otherwise acquiring any interest in any security of the corporation shall be deemed to have notice of and consented to the provisions of this Section 9.5. This provision shall be enforceable by any party to a complaint covered by the provisions of this Section 9.5. For the avoidance of doubt, nothing contained in this Section 9.5 shall apply to any action brought to enforce a duty or liability created by the 1934 Act or any successor thereto.

ARTICLE X - AMENDMENTS

These bylaws may be adopted, amended, altered or repealed by the stockholders entitled to vote; provided, however, that the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%) of the total voting power of outstanding voting securities, voting together as a single class, shall be required for the stockholders of the corporation to alter, amend or repeal, or adopt any provision of these bylaws. The board of directors shall also have the power to adopt, amend or repeal bylaws.

A bylaw amendment adopted by stockholders which specifies the votes that shall be necessary for the election of directors shall not be further amended or repealed by the board of directors.

-24-

EX-31.1

Exhibit 31.1

NLIGHT, INC.

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a - 14(a) OR RULE 15d - 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Scott Keeney, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of nLIGHT, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2023

/s/ SCOTT KEENEY

Scott Keeney

President, Chief Executive Officer and Chairman (Principal Executive Officer)

EX-31.2

Exhibit 31.2

NLIGHT, INC.

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a - 14(a) OR RULE 15d - 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Joseph Corso, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of nLIGHT, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2023

/s/ JOSEPH CORSO

Joseph Corso

Chief Financial Officer (Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report") by nLIGHT, Inc. (the "Company"), Scott Keeney, as the Chief Executive Officer of the Company, and Joseph Corso, as the Chief Financial Officer of the Company, each hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

1.the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 5, 2023

/s/ SCOTT KEENEY

Scott Keeney

President, Chief Executive Officer and Chairman (Principal Executive Officer)

/s/ JOSEPH CORSO

Joseph Corso

Chief Financial Officer (Principal Financial Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 02, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Current Fiscal Year End Date	--12-31
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-38462
Entity Registrant Name	NLIGHT, INC.
Entity Incorporation, Date of Incorporation	DE
Entity Tax Identification Number	91-2066376
Entity Address, Address Line One	4637 NW 18th Avenue
Entity Address, City or Town	Camas
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98607
City Area Code	360
Local Phone Number	566-4460
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	LASR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Smaller Reporting Company	false
Emerging Growth	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		45,850,661
Entity Central Index Key	0001124796
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 48,402	$ 57,826
Marketable securities	59,966	50,391
Accounts receivable, net of allowances of $290 and $290	36,140	37,913
Inventory	67,157	67,600
Prepaid expenses and other current assets	21,586	17,026
Total current assets	233,251	230,756
Restricted cash	253	252
Lease right-of-use assets	13,900	13,893
Property, plant and equipment, net	58,978	60,693
Intangible assets, net	3,408	4,041
Goodwill	12,388	12,376
Other assets, net	7,586	7,222
Total assets	329,764	329,233
Current liabilities:
Accounts payable	17,759	17,507
Accrued liabilities	14,708	12,820
Deferred revenues	1,271	1,407
Current portion of lease liabilities	3,001	2,758
Total current liabilities	36,739	34,492
Non-current income taxes payable	6,920	6,699
Long-term lease liabilities	12,576	12,852
Other long-term liabilities	4,367	4,345
Total liabilities	60,602	58,388
Stockholders' equity:
Common stock - $0.0001 par value; 190,000 shares authorized, 45,785 and 45,629 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	16	16
Additional paid-in capital	501,675	496,211
Accumulated other comprehensive loss	(2,165)	(2,748)
Accumulated deficit	(230,364)	(222,634)
Total stockholders’ equity	269,162	270,845
Total liabilities and stockholders’ equity	$ 329,764	$ 329,233

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 290	$ 290
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	190,000	190,000
Common stock, shares issued (in shares)	45,785	45,629
Common stock, shares outstanding (in shares)	45,785	45,629

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenue	$ 54,091	$ 64,459
Total cost of revenue	39,828	48,282
Gross profit	14,263	16,177
Operating expenses:
Research and development	11,301	13,711
Sales, general, and administrative	11,169	10,775
Total operating expenses	22,470	24,486
Loss from operations	(8,207)	(8,309)
Other income:
Interest income (expense), net	337	0
Other income, net	404	29
Loss before income taxes	(7,466)	(8,280)
Income tax expense (benefit)	264	343
Net loss	$ (7,730)	$ (8,623)
Net loss per share, basic (in dollars per share)	$ (0.17)	$ (0.20)
Net loss per share, diluted (in dollars per share)	$ (0.17)	$ (0.20)
Shares used in per share calculations, basic (in shares)	45,706	43,655
Shares used in per share calculations, diluted (in shares)	45,706	43,655
Products
Total revenue	$ 41,107	$ 51,061
Total cost of revenue	27,526	35,768
Development
Total revenue	12,984	13,398
Total cost of revenue	$ 12,302	$ 12,514

XML

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (7,730)	$ (8,623)
Other comprehensive loss, net of tax:
Foreign currency translation adjustments	369	(96)
Unrealized gains on available-for-sale securities	214	0
Comprehensive loss	$ (7,147)	$ (8,719)

XML

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021		44,248
Beginning balance at Dec. 31, 2021	$ 302,133	$ 15	$ 470,760	$ (587)	$ (168,055)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,623)				(8,623)
Issuance of common stock pursuant to exercise of stock options (in shares)		423
Issuance of common stock pursuant to exercise of stock options	689		689
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax (in shares)		7
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax	(78)		(78)
Restricted stock awards forfeited in connection with transition agreement (in shares)		(140)
Stock-based compensation	6,553		6,553
Cumulative translation adjustment, net of tax	(96)			(96)
Ending balance (in shares) at Mar. 31, 2022		44,538
Ending balance at Mar. 31, 2022	$ 300,578	$ 15	477,924	(683)	(176,678)
Beginning balance (in shares) at Dec. 31, 2022	45,629	45,629
Beginning balance at Dec. 31, 2022	$ 270,845	$ 16	496,211	(2,748)	(222,634)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (7,730)				(7,730)
Issuance of common stock pursuant to exercise of stock options (in shares)	117	117
Issuance of common stock pursuant to exercise of stock options	$ 143		143
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax (in shares)		39
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax	(182)		(182)
Stock-based compensation	5,503		5,503
Unrealized gains on available-for-sale securities	214			214
Cumulative translation adjustment, net of tax	$ 369			369
Ending balance (in shares) at Mar. 31, 2023	45,785	45,785
Ending balance at Mar. 31, 2023	$ 269,162	$ 16	$ 501,675	$ (2,165)	$ (230,364)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (7,730)	$ (8,623)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	3,105	2,556
Amortization	872	1,182
Reduction in carrying amount of right-of-use assets	6	867
Recoveries of losses on accounts receivable	(2)	0
Stock-based compensation	5,503	6,553
Deferred income taxes	0	(4)
Changes in operating assets and liabilities:
Accounts receivable, net	1,905	4,690
Inventory	662	(3,433)
Prepaid expenses and other current assets	(4,549)	(5,061)
Other assets, net	(540)	(317)
Accounts payable	(411)	(3,019)
Accrued and other long-term liabilities	1,855	(1,088)
Deferred revenues	(142)	(647)
Lease liabilities	(45)	(813)
Non-current income taxes payable	155	153
Net cash provided by (used in) operating activities	644	(7,004)
Cash flows from investing activities:
Purchases of property, plant and equipment	(684)	(5,019)
Acquisition of intangible assets and capitalization of patents	0	(114)
Purchase of marketable securities	(34,359)	0
Proceeds from maturities and sales of marketable securities	24,998	0
Net cash used in investing activities	(10,045)	(5,133)
Cash flows from financing activities:
Proceeds from stock option exercises	143	689
Tax payments related to stock award issuances	(182)	(78)
Net cash (used in) provided by financing activities	(39)	611
Effect of exchange rate changes on cash	17	(59)
Net decrease in cash, cash equivalents, and restricted cash	(9,423)	(11,585)
Cash, cash equivalents, and restricted cash, beginning of period	58,078	146,784
Cash, cash equivalents, and restricted cash, end of period	48,655	135,199
Supplemental disclosures:
Cash paid for interest, net	0	0
Cash paid for income taxes	144	79
Operating cash outflows from operating leases	923	1,097
Right-of-use assets obtained in exchange for lease liabilities	731	1,470
Accrued purchases of property, equipment and patents	$ 697	$ 2,268

XML

Basis of Presentation and New Accounting Pronouncements

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation and New Accounting Pronouncements

Basis of Presentation and New Accounting Pronouncements

Basis of Presentation

The accompanying unaudited consolidated financial statements of nLIGHT, Inc. and our wholly-owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The unaudited financial information reflects, in the opinion of management, all adjustments necessary for a fair presentation of financial position, results of operations, stockholders’ equity, and cash flows for the interim periods presented. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.

Critical Accounting Policies

Our critical accounting policies have not materially changed during the three months ended March 31, 2023, from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

New Accounting Pronouncements

None.

XML

Revenue

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

We recognize revenue upon transferring control of products and services and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. As part of our consideration of the contract, we evaluate certain factors, including the customer's ability to pay (or credit risk). For each contract, we consider the promise to transfer products, each of which is distinct, as the identified performance obligations.

We allocate the transaction price to each distinct product based on its relative standalone selling price. Master sales agreements or purchase orders from customers could include a single product or multiple products. Regardless, the contracted price with the customer is agreed to at the individual product level outlined in the customer contract or purchase order. We do not bundle prices; however, we do negotiate with customers on pricing for the same products based on a variety of factors (e.g., level of contractual volume). We have concluded that the prices negotiated with each individual customer are representative of the stand-alone selling price of the product.

We often receive orders with multiple delivery dates that may extend across several reporting periods. We allocate the transaction price of the contract to each delivery based on the product standalone selling price and invoice for each scheduled delivery upon shipment or delivery and recognize revenues for such delivery at that point, when transfer of control has occurred. As scheduled delivery dates are generally within one year, under the optional exemption provided by ASC 606-10-50-14a revenues allocated to future shipments of partially completed contracts are not disclosed as performance obligations for point in time revenue. Further, the Company recognizes over time revenue as per ASC 606-10-55-18 (invoice practical expedient) for its cost plus contracts and, accordingly, elects not to disclose information related to those performance obligations under ASC 606-10-50-14b.

Rights of return generally are not included in customer contracts. Accordingly, product revenue is recognized upon transfer of control at shipment or delivery, as applicable. Rights of return are evaluated as they occur.

Revenues recognized at a point in time consist of sales of semiconductor lasers, fiber lasers and other related products. Revenues recognized over time generally consist of development arrangements that are structured based on our costs incurred. Because control transfers over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. We generally use the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer. Billing under these arrangements generally occurs within one month after the work is completed.

The following tables represent a disaggregation of revenue from contracts with customers for the periods presented (in thousands):

Sales by End Market

	Three Months Ended March 31,
	2023		2022
Industrial	$	19,902	$	23,996
Microfabrication	13,058		17,319
Aerospace and Defense	21,131		23,144
	$	54,091	$	64,459

Sales by Geography

	Three Months Ended March 31,
	2023		2022
North America	$	29,103	$	35,144
China	3,646		7,139
Rest of World	21,342		22,176
	$	54,091	$	64,459

Sales by Timing of Revenue

	Three Months Ended March 31,
	2023		2022
Point in time	$	40,272	$	48,215
Over time	13,819		16,244
	$	54,091	$	64,459

Our contract assets and liabilities are as follows (in thousands):

	Balance Sheet Classification	As of
		March 31, 2023		December 31, 2022
Contract assets	Prepaid expenses and other current assets	$	16,547	$	10,377
Contract liabilities	Deferred revenues and other long-term liabilities	2,511		2,455

Contract assets generally consist of revenue recognized on an over time basis where revenue recognition has been met, but the amounts are subsequently billed and collected in the following period.

During the three months ended March 31, 2023 and 2022, we recognized revenue of $0.8 million and $1.4 million, respectively, that was included in the deferred revenue balances at the beginning of the period as the performance obligations under the associated agreements were satisfied.

XML

Concentrations of Credit and Other Risks

3 Months Ended

Mar. 31, 2023

Risks and Uncertainties [Abstract]

Concentrations of Credit and Other Risks

Concentrations of Credit and Other Risks

The following customers accounted for 10% or more of our revenues for the periods presented:

	Three Months Ended March 31,
	2023	2022
U.S. Government	16%	17%
Raytheon Technologies	(1)	10%

(1)Represents less than 10% of total revenues.

Financial instruments that potentially expose us to concentrations of credit risk consist principally of receivables from customers. As of March 31, 2023, and December 31 2022, two customers accounted for a total of 33% and 29%, respectively, of net customer receivables. No other customers accounted for 10% or more of net customer receivables at either date.

XML

Marketable Securities

3 Months Ended

Mar. 31, 2023

Investments, All Other Investments [Abstract]

Marketable Securities

Marketable Securities

Marketable securities consist primarily of highly liquid investments with original maturities of greater than 90 days when purchased. Our marketable securities are considered available-for-sale as they represent investments that are available to be sold for current operations. As such, they are included as current assets on our Consolidated Balance Sheets at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Any unrealized gains and losses that are considered to be other-than-temporary are recorded in other income, net on our Consolidated Statements of Operations. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in other income, net on our Consolidated Statements of Operations.

Realized gains were $0.4 million for three months ended March 31, 2023. Unrealized gains were $0.2 million for the three months ended March 31, 2023. These unrealized gains are considered temporary and are reflected in the Statements of Comprehensive Loss. There were no realized or unrealized gains or losses for the three months ended March 31, 2022.

See Note 5 for additional information.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying amounts of certain of our financial instruments, including cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities are shown at cost which approximates fair value due to the short-term nature of these instruments. The fair value of our term and revolving loans approximates the carrying value due to the variable market rate used to calculate interest payments.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value which are the following:

•Level 1 Inputs: Observable inputs, such as quoted prices (unadjusted) in active markets for identical assets or liabilities at the measurement date.

•Level 2 Inputs: Observable inputs, other than Level 1 prices, such as quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•Level 3 Inputs: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Our financial instruments that are carried at fair value consist of Level 1 assets which include highly liquid investments and bank drafts classified as cash equivalents and marketable securities.

Our fair value hierarchy for our financial instruments was as follows (in thousands):

	March 31, 2023
	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market securities	$	26,000	$	—	$	—	$	26,000
Commercial paper	557		—		—		557
	26,557		—		—		26,557
Marketable Securities:
U.S. treasuries	59,966		—		—		59,966
Total	$	86,523	$	—	$	—	$	86,523

	December 31, 2022
	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market securities	$	31,658	$	—	$	—	$	31,658
Commercial paper	656		—		—		656
	$	32,314	$	—	$	—	$	32,314
Marketable Securities:
U.S. treasuries	50,391		—		—		50,391
Total	$	82,705	$	—	$	—	$	82,705

Cash Equivalents

The fair value of cash equivalents is determined based on quoted market prices for similar or identical securities.

Marketable Securities

We classify our marketable securities as available-for-sale and value them utilizing a market approach that uses observable inputs without applying significant judgment.

XML

Inventory

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Inventory

Inventory

Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

Inventory consisted of the following (in thousands):

	As of
	March 31, 2023		December 31, 2022
Raw materials	$	32,665	$	32,515
Work in process and semi-finished goods	20,137		19,056
Finished goods	14,355		16,029
	$	67,157	$	67,600

XML

Property, Plant and Equipment

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment consist of the following (in thousands):

	Useful life	As of
	(years)	March 31, 2023		December 31, 2022
Automobiles	3	$	114	$	110
Computer hardware and software	3 - 5	8,673		8,712
Manufacturing and lab equipment	2 - 7	90,153		89,230
Office equipment and furniture	5 - 7	2,482		2,410
Leasehold and building improvements	2 - 12	31,217		30,675
Buildings	30	9,392		9,392
Land	N/A	3,399		3,399
		145,430		143,928
Accumulated depreciation		(86,452)		(83,235)
		$	58,978	$	60,693

XML

Intangible Assets and Goodwill

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

Intangible Assets and Goodwill

Intangible Assets

The details of definite lived intangible assets were as follows (in thousands):

	Estimated useful life (in years)	As of
		March 31, 2023		December 31, 2022
Patents	3 - 5	$	6,334	$	6,322
Development programs	2 - 4	7,200		7,200
Developed technology	5	2,960		2,930
		16,494		16,452
Accumulated amortization		(13,086)		(12,411)
		$	3,408	$	4,041

Amortization related to intangible assets was as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Amortization expense	$	654	$	776

Estimated amortization expense for future years is as follows (in thousands):

2023	$	1,581
2024	929
2025	593
2026	305
Thereafter	—
	$	3,408

Goodwill

The carrying amount of goodwill by segment was as follows (in thousands):

	Laser Products		Advanced Development		Totals
Balance, December 31, 2022	$	2,128	$	10,248	$	12,376
Currency exchange rate adjustment	12		—		12
Balance, March 31, 2023	$	2,140	$	10,248	$	12,388

XML

Accrued Liabilities

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Accrued Liabilities

Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

	As of
	March 31, 2023		December 31, 2022
Accrued payroll and benefits	$	9,888	$	8,233
Product warranty, current	2,540		2,601
Other accrued expenses	2,280		1,986
	$	14,708	$	12,820

XML

Product Warranties

3 Months Ended

Mar. 31, 2023

Guarantees and Product Warranties [Abstract]

Product Warranties

Product Warranties

We provide warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based on historical experience, any specifically identified failures, and our estimate of future costs. The current portion of our product warranty liability is included in the accrued liabilities and the long-term portion is included in other long-term liabilities in our Consolidated Balance Sheets.

Product warranty liability activity was as follows for the periods presented (in thousands):

	Three Months Ended March 31,
	2023		2022
Product warranty liability, beginning	$	5,441	$	5,371
Warranty charges incurred, net	(782)		(1,490)
Provision for warranty charges, net of adjustments	572		1,560
Product warranty liability, ending	5,231		5,441
Less: current portion of product warranty liability	(2,540)		(2,601)
Non-current portion of product warranty liability	$	2,691	$	2,840

XML

Stockholders' Equity and Stock-Based Compensation

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Stockholders' Equity and Stock-Based Compensation

Stockholders' Equity and Stock-Based Compensation

Restricted Stock Awards and Units

There was no restricted stock award activity in the first quarter of 2023. Restricted stock unit ("RSU") activity under our equity incentive plan was as follows (in thousands, except weighted-average grant date fair values):

		Number of Restricted Stock Units	Weighted-Average Grant Date Fair Value
RSUs at December 31, 2022		2,784	$	17.63
	Awards granted	152	11.55
	Awards vested	(57)	18.09
	Awards forfeited	(223)	21.49
RSUs at March 31, 2023		2,656	16.95

The total fair value of RSUs vested during the three months ended March 31, 2023, was $1.0 million. Awards outstanding as of March 31, 2023 include 0.6 million performance-based awards that will vest upon meeting certain performance criteria.

Stock Options

The following table summarizes our stock option activity during the three months ended March 31, 2023 (in thousands, except weighted-average exercise prices):

	Number of Options	Weighted-Average Exercise Price	Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding, December 31, 2022	1,827	$1.29	3.4	$16,156
Options exercised	(117)	1.22
Outstanding, March 31, 2023	1,710	1.30	3.2	15,181
Options exercisable at March 31, 2023	1,710	1.30	3.2	15,181
Options vested as of March 31, 2023, and expected to vest after March 31, 2023	1,710	1.30	3.2	15,181

Total intrinsic value of options exercised for the three months ended March 31, 2023 and 2022, was $1.1 million and $6.4 million, respectively. We received proceeds of $0.1 million and $0.7 million from the exercise of options for the three months ended March 31, 2023 and 2022, respectively.

Stock-Based Compensation

Total stock-based compensation expense was included in our consolidated statements of operations as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Cost of revenues	$	700	$	709
Research and development	2,098		3,122
Sales, general and administrative	2,705		2,722
	$	5,503	$	6,553

Unrecognized Compensation Costs

As of March 31, 2023, total unrecognized stock-based compensation was $34.8 million, which will be recognized over an average expected recognition period of 2.0 years.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Leases

See Note 13.

Legal Matters

On March 25, 2022, Lumentum Operations LLC filed a complaint against nLIGHT, Inc. and certain of its employees in the U.S. District Court for the Western District of Washington. The complaint alleges that Lumentum is the partial or full owner of certain of our patents and requests corresponding relief from the court. We are vigorously defending against Lumentum’s allegations. Loss in this matter is not probable or reasonably estimable and, as such, no loss contingency has been recorded.

From time to time, we may be subject to various other legal proceedings and claims in the ordinary course of business. As of March 31, 2023, we believe these matters will not have a material adverse effect on our consolidated financial statements.

XML

Leases

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Leases

Leases

We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space. Facilities-related operating leases have remaining terms of one month to 12.2 years, and some leases include options to extend up to 15 years. Other leases for automobiles, manufacturing and office and computer equipment have remaining lease terms of 0.2 to 4.3 years. These leases are primarily operating leases; financing leases are not material. We did not include any renewal options in our lease terms for calculating the lease liabilities as we are not reasonably certain we will exercise the options at this time. The weighted-average remaining lease term for the lease obligations was 8 years as of March 31, 2023, and the weighted-average discount rate was 3.6%. The weighted-average remaining lease term for the lease obligations was 8 years as of December 31, 2022, and the weighted-average discount rate was 3.6%.

The components of lease expense related to operating leases were as follows (in thousands):

		Three Months Ended March 31,
		2023		2022
Lease expense:
	Operating lease expense	$	921	$	1,031
	Short-term lease expense	93		121
	Variable and other lease expense	225		194
		$	1,239	$	1,346

Future minimum payments under our non-cancelable lease obligations were as follows as of March 31, 2023 (in thousands):

2023	$	2,658
2024	3,232
2025	2,067
2026	1,654
2027	1,655
Thereafter	6,806
Total minimum lease payments	18,072
Less: interest	(2,495)
Present value of net minimum lease payments	15,577
Less: current portion of lease liabilities	(3,001)
Total long-term lease liabilities	$	12,576

XML

Segment Information

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Segment Information

Segment Information

We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. The following table summarizes the operating results by reportable segment (dollars in thousands):

	Three Months Ended March 31, 2023
	Laser Products			Advanced Development			Corporate and Other		Totals
Revenue	$	41,107		$	12,984		$	—	$	54,091
Gross profit	$	14,281		$	682		$	(700)	$	14,263
Gross margin	34.7		%	5.3		%	NM*		26.4		%

	Three Months Ended March 31, 2022
	Laser Products			Advanced Development			Corporate and Other		Totals
Revenue	$	51,061		$	13,398		$	—	$	64,459
Gross profit	$	16,002		$	884		$	(709)	$	16,177
Gross margin	31.3		%	6.6		%	NM*		25.1		%

Corporate and Other is unallocated expenses related to stock-based compensation.

There have been no material changes to the geographic locations of our long-lived assets, net, based on the location of the assets, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

XML

Net Loss per Share

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Net Loss per Share

Net Loss per Share

Basic and diluted net loss and the number of shares used for basic and diluted net loss calculations were the same for all periods presented because we were in a loss position.

The following potentially dilutive securities were not included in the calculation of diluted shares as the effect would have been anti‑dilutive (in thousands):

	Three Months Ended March 31,
	2023	2022
Restricted stock units and awards	845	1,313
Common stock options	1,574	2,090
	2,419	3,403

XML

Subsequent Event	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Event	Subsequent EventOn May 4, 2023, we announced that we had been awarded an $86 million contract to produce a High Energy Laser (HEL) prototype for the next phase of development in support of the U.S. Department of Defense’s (DoD) High Energy Laser Scaling Initiative (HELSI).

XML

Basis of Presentation and New Accounting Pronouncements (Policies)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited consolidated financial statements of nLIGHT, Inc. and our wholly-owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The unaudited financial information reflects, in the opinion of management, all adjustments necessary for a fair presentation of financial position, results of operations, stockholders’ equity, and cash flows for the interim periods presented. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.

New Accounting Pronouncements

New Accounting Pronouncements

None.

Inventory

Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

Product Warranties

We provide warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based on historical experience, any specifically identified failures, and our estimate of future costs. The current portion of our product warranty liability is included in the accrued liabilities and the long-term portion is included in other long-term liabilities in our Consolidated Balance Sheets.

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Sales by End Market

The following tables represent a disaggregation of revenue from contracts with customers for the periods presented (in thousands):

Sales by End Market

	Three Months Ended March 31,
	2023		2022
Industrial	$	19,902	$	23,996
Microfabrication	13,058		17,319
Aerospace and Defense	21,131		23,144
	$	54,091	$	64,459

Schedule of Sales by Geography

Sales by Geography

	Three Months Ended March 31,
	2023		2022
North America	$	29,103	$	35,144
China	3,646		7,139
Rest of World	21,342		22,176
	$	54,091	$	64,459

Schedule of Sales by Timing of Revenue

Sales by Timing of Revenue

	Three Months Ended March 31,
	2023		2022
Point in time	$	40,272	$	48,215
Over time	13,819		16,244
	$	54,091	$	64,459

Schedule of Contract Assets and Liabilities

Our contract assets and liabilities are as follows (in thousands):

	Balance Sheet Classification	As of
		March 31, 2023		December 31, 2022
Contract assets	Prepaid expenses and other current assets	$	16,547	$	10,377
Contract liabilities	Deferred revenues and other long-term liabilities	2,511		2,455

XML

Concentrations of Credit and Other Risks (Tables)

3 Months Ended

Mar. 31, 2023

Risks and Uncertainties [Abstract]

Schedule of Concentration of Credit

The following customers accounted for 10% or more of our revenues for the periods presented:

	Three Months Ended March 31,
	2023	2022
U.S. Government	16%	17%
Raytheon Technologies	(1)	10%

(1)Represents less than 10% of total revenues.

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy for Its Cash Equivalents

Our fair value hierarchy for our financial instruments was as follows (in thousands):

	March 31, 2023
	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market securities	$	26,000	$	—	$	—	$	26,000
Commercial paper	557		—		—		557
	26,557		—		—		26,557
Marketable Securities:
U.S. treasuries	59,966		—		—		59,966
Total	$	86,523	$	—	$	—	$	86,523

	December 31, 2022
	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market securities	$	31,658	$	—	$	—	$	31,658
Commercial paper	656		—		—		656
	$	32,314	$	—	$	—	$	32,314
Marketable Securities:
U.S. treasuries	50,391		—		—		50,391
Total	$	82,705	$	—	$	—	$	82,705

XML

Inventory (Tables)

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Components of Inventory

Inventory consisted of the following (in thousands):

	As of
	March 31, 2023		December 31, 2022
Raw materials	$	32,665	$	32,515
Work in process and semi-finished goods	20,137		19,056
Finished goods	14,355		16,029
	$	67,157	$	67,600

XML

Property, Plant and Equipment (Tables)

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property, plant and equipment consist of the following (in thousands):

	Useful life	As of
	(years)	March 31, 2023		December 31, 2022
Automobiles	3	$	114	$	110
Computer hardware and software	3 - 5	8,673		8,712
Manufacturing and lab equipment	2 - 7	90,153		89,230
Office equipment and furniture	5 - 7	2,482		2,410
Leasehold and building improvements	2 - 12	31,217		30,675
Buildings	30	9,392		9,392
Land	N/A	3,399		3,399
		145,430		143,928
Accumulated depreciation		(86,452)		(83,235)
		$	58,978	$	60,693

XML

Intangible Assets and Goodwill (Tables)

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

The details of definite lived intangible assets were as follows (in thousands):

	Estimated useful life (in years)	As of
		March 31, 2023		December 31, 2022
Patents	3 - 5	$	6,334	$	6,322
Development programs	2 - 4	7,200		7,200
Developed technology	5	2,960		2,930
		16,494		16,452
Accumulated amortization		(13,086)		(12,411)
		$	3,408	$	4,041

Schedule of Finite-lived Intangible Assets Amortization Expense

Amortization related to intangible assets was as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Amortization expense	$	654	$	776

Schedule of Estimated Future Amortization Expense

Estimated amortization expense for future years is as follows (in thousands):

2023	$	1,581
2024	929
2025	593
2026	305
Thereafter	—
	$	3,408

Schedule of Goodwill

The carrying amount of goodwill by segment was as follows (in thousands):

	Laser Products		Advanced Development		Totals
Balance, December 31, 2022	$	2,128	$	10,248	$	12,376
Currency exchange rate adjustment	12		—		12
Balance, March 31, 2023	$	2,140	$	10,248	$	12,388

XML

Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

	As of
	March 31, 2023		December 31, 2022
Accrued payroll and benefits	$	9,888	$	8,233
Product warranty, current	2,540		2,601
Other accrued expenses	2,280		1,986
	$	14,708	$	12,820

XML

Product Warranties (Tables)

3 Months Ended

Mar. 31, 2023

Guarantees and Product Warranties [Abstract]

Schedule of Reconciliation of the Changes in the Aggregate Product Warranty Liability

Product warranty liability activity was as follows for the periods presented (in thousands):

	Three Months Ended March 31,
	2023		2022
Product warranty liability, beginning	$	5,441	$	5,371
Warranty charges incurred, net	(782)		(1,490)
Provision for warranty charges, net of adjustments	572		1,560
Product warranty liability, ending	5,231		5,441
Less: current portion of product warranty liability	(2,540)		(2,601)
Non-current portion of product warranty liability	$	2,691	$	2,840

XML

Stockholders' Equity and Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Schedule of Restricted Stock Awards and Units

There was no restricted stock award activity in the first quarter of 2023. Restricted stock unit ("RSU") activity under our equity incentive plan was as follows (in thousands, except weighted-average grant date fair values):

		Number of Restricted Stock Units	Weighted-Average Grant Date Fair Value
RSUs at December 31, 2022		2,784	$	17.63
	Awards granted	152	11.55
	Awards vested	(57)	18.09
	Awards forfeited	(223)	21.49
RSUs at March 31, 2023		2,656	16.95

Schedule of Stock Option Activity

The following table summarizes our stock option activity during the three months ended March 31, 2023 (in thousands, except weighted-average exercise prices):

	Number of Options	Weighted-Average Exercise Price	Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding, December 31, 2022	1,827	$1.29	3.4	$16,156
Options exercised	(117)	1.22
Outstanding, March 31, 2023	1,710	1.30	3.2	15,181
Options exercisable at March 31, 2023	1,710	1.30	3.2	15,181
Options vested as of March 31, 2023, and expected to vest after March 31, 2023	1,710	1.30	3.2	15,181

Schedule of Stock-based Compensation Expense

Total stock-based compensation expense was included in our consolidated statements of operations as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Cost of revenues	$	700	$	709
Research and development	2,098		3,122
Sales, general and administrative	2,705		2,722
	$	5,503	$	6,553

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Schedule of Components of Lease Expense

The components of lease expense related to operating leases were as follows (in thousands):

		Three Months Ended March 31,
		2023		2022
Lease expense:
	Operating lease expense	$	921	$	1,031
	Short-term lease expense	93		121
	Variable and other lease expense	225		194
		$	1,239	$	1,346

Schedule of Future Minimum Payments Under Non-cancelable Lease Obligations

Future minimum payments under our non-cancelable lease obligations were as follows as of March 31, 2023 (in thousands):

2023	$	2,658
2024	3,232
2025	2,067
2026	1,654
2027	1,655
Thereafter	6,806
Total minimum lease payments	18,072
Less: interest	(2,495)
Present value of net minimum lease payments	15,577
Less: current portion of lease liabilities	(3,001)
Total long-term lease liabilities	$	12,576

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of Operating Results by Reportable Segment

The following table summarizes the operating results by reportable segment (dollars in thousands):

	Three Months Ended March 31, 2023
	Laser Products			Advanced Development			Corporate and Other		Totals
Revenue	$	41,107		$	12,984		$	—	$	54,091
Gross profit	$	14,281		$	682		$	(700)	$	14,263
Gross margin	34.7		%	5.3		%	NM*		26.4		%

	Three Months Ended March 31, 2022
	Laser Products			Advanced Development			Corporate and Other		Totals
Revenue	$	51,061		$	13,398		$	—	$	64,459
Gross profit	$	16,002		$	884		$	(709)	$	16,177
Gross margin	31.3		%	6.6		%	NM*		25.1		%

XML

Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Schedule of Potentially Dilutive Shares Not Included in Calculation of Diluted Shares

The following potentially dilutive securities were not included in the calculation of diluted shares as the effect would have been anti‑dilutive (in thousands):

	Three Months Ended March 31,
	2023	2022
Restricted stock units and awards	845	1,313
Common stock options	1,574	2,090
	2,419	3,403

XML

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 54,091	$ 64,459
Point in time
Disaggregation of Revenue [Line Items]
Total revenue	40,272	48,215
Over time
Disaggregation of Revenue [Line Items]
Total revenue	13,819	16,244
North America
Disaggregation of Revenue [Line Items]
Total revenue	29,103	35,144
China
Disaggregation of Revenue [Line Items]
Total revenue	3,646	7,139
Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	21,342	22,176
Industrial
Disaggregation of Revenue [Line Items]
Total revenue	19,902	23,996
Microfabrication
Disaggregation of Revenue [Line Items]
Total revenue	13,058	17,319
Aerospace and Defense
Disaggregation of Revenue [Line Items]
Total revenue	$ 21,131	$ 23,144

XML

Revenue - Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Contract assets	$ 16,547	$ 10,377
Contract liabilities	$ 2,511	$ 2,455

XML

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue recognized, previously included in customer advances and deferred revenue	$ 0.8	$ 1.4

XML

Concentrations of Credit and Other Risks (Details) - Customer Concentration Risk	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Sales Revenue | U.S. Government
Concentration Risk [Line Items]
Concentration risk (as a percent)	16.00%	17.00%
Sales Revenue | Raytheon Technologies
Concentration Risk [Line Items]
Concentration risk (as a percent)		10.00%
Accounts Receivable | Two customers
Concentration Risk [Line Items]
Concentration risk (as a percent)	33.00%	29.00%

XML

Marketable Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Investments, All Other Investments [Abstract]
Realized gains	$ 0.4	$ 0.0
Unrealized gains	$ 0.2	$ 0.0

XML

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	$ 26,557	$ 82,705
Total	86,523	32,314
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	26,557	32,314
Total	86,523	82,705
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	0	0
Total	0	0
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	0	0
Total	0	0
Money market securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	26,000	31,658
Money market securities | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	26,000	31,658
Money market securities | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	0	0
Money market securities | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	0	0
Commercial paper
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	557	656
Commercial paper | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	557	656
Commercial paper | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	0	0
Commercial paper | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents:	0	0
U.S. treasuries
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities:	59,966	50,391
U.S. treasuries | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities:	59,966	50,391
U.S. treasuries | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities:	0	0
U.S. treasuries | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities:	$ 0	$ 0

XML

Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 32,665	$ 32,515
Work in process and semi-finished goods	20,137	19,056
Finished goods	14,355	16,029
Inventory	$ 67,157	$ 67,600

XML

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 145,430	$ 143,928
Accumulated depreciation	(86,452)	(83,235)
Property and equipment, net	$ 58,978	60,693
Automobiles
Property, Plant and Equipment [Line Items]
(years)	3 years
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 114	110
Computer hardware and software
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 8,673	8,712
Computer hardware and software | Minimum
Property, Plant and Equipment [Line Items]
(years)	3 years
Computer hardware and software | Maximum
Property, Plant and Equipment [Line Items]
(years)	5 years
Manufacturing and lab equipment
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 90,153	89,230
Manufacturing and lab equipment | Minimum
Property, Plant and Equipment [Line Items]
(years)	2 years
Manufacturing and lab equipment | Maximum
Property, Plant and Equipment [Line Items]
(years)	7 years
Office equipment and furniture
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 2,482	2,410
Office equipment and furniture | Minimum
Property, Plant and Equipment [Line Items]
(years)	5 years
Office equipment and furniture | Maximum
Property, Plant and Equipment [Line Items]
(years)	7 years
Leasehold and building improvements
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 31,217	30,675
Leasehold and building improvements | Minimum
Property, Plant and Equipment [Line Items]
(years)	2 years
Leasehold and building improvements | Maximum
Property, Plant and Equipment [Line Items]
(years)	12 years
Buildings
Property, Plant and Equipment [Line Items]
(years)	30 years
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 9,392	9,392
Land
Property, Plant and Equipment, Net [Abstract]
Property and equipment, gross	$ 3,399	$ 3,399

XML

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 16,494		$ 16,452
Accumulated amortization	(13,086)		(12,411)
Net value	3,408		4,041
Amortization expense	654	$ 776
Patents
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	6,334		6,322
Development programs
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 7,200		7,200
Developed technology
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	5 years
Gross carrying amount	$ 2,960		$ 2,930
Minimum | Patents
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	3 years
Minimum | Development programs
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	2 years
Maximum | Patents
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	5 years
Maximum | Development programs
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	4 years

XML

Intangible Assets and Goodwill - Amortization of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 1,581
2024	929
2025	593
2026	305
Thereafter	0
Net value	$ 3,408	$ 4,041

XML

Intangible Assets and Goodwill - Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 12,376
Currency exchange rate adjustment	12
Ending balance	12,388
Laser Products
Goodwill [Roll Forward]
Beginning balance	2,128
Currency exchange rate adjustment	12
Ending balance	2,140
Advanced Development
Goodwill [Roll Forward]
Beginning balance	10,248
Currency exchange rate adjustment	0
Ending balance	$ 10,248

XML

Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued payroll and benefits	$ 9,888	$ 8,233
Product warranty, current	2,540	2,601
Other accrued expenses	2,280	1,986
Total accrued liabilities	$ 14,708	$ 12,820

XML

Product Warranties (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Product warranty liability, beginning	$ 5,441	$ 5,371
Warranty charges incurred, net	(782)	(1,490)
Provision for warranty charges, net of adjustments	572	1,560
Product warranty liability, ending	5,231	5,441
Less: current portion of product warranty liability	(2,540)	(2,601)
Non-current portion of product warranty liability	$ 2,691	$ 2,840

XML

Stockholders' Equity and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Number of Restricted Stock Units
Balance, beginning (in shares) | shares	2,784
Awards granted (in shares) | shares	152
Awards vested (in shares) | shares	(57)
Awards forfeited (in shares) | shares	(223)
Balance, ending (in shares) | shares	2,656
Weighted-Average Grant Date Fair Value
Balance, beginning (in dollars per share) | $ / shares	$ 17.63
Awards granted (in dollars per share) | $ / shares	11.55
Awards vested (in dollars per share) | $ / shares	18.09
Awards forfeited (in dollars per share) | $ / shares	21.49
Balance, ending (in dollars per share) | $ / shares	$ 16.95

XML

Stockholders' Equity and Stock-Based Compensation - Narrative (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of options exercised	$ 1,100	$ 6,400
Proceeds from stock option exercises	143	$ 689
Unrecognized expense	$ 34,800
Period for recognition (in years)	2 years
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, fair value	$ (1,000)
Awards outstanding (in shares)	2,656		2,784
Performance-based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (in shares)	600

XML

Stockholders' Equity and Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Number of Options
Outstanding, beginning of period (in shares)	1,827
Options exercised (in shares)	(117)
Outstanding, end of period (in shares)	1,710	1,827
Weighted-Average Exercise Price
Outstanding, beginning of period (in dollars per share)	$ 1.29
Options exercised (in dollars per share)	1.22
Outstanding, end of period (in dollars per share)	$ 1.30	$ 1.29
Outstanding, Weighted average remaining contractual term (in years)	3 years 2 months 12 days	3 years 4 months 24 days
Outstanding, Aggregate intrinsic value	$ 15,181	$ 16,156
Options exercisable at end of period
Options exercisable (in shares)	1,710
Weighted average exercise price (in dollars per share)	$ 1.30
Weighted-Average Remaining Contractual Term (Years)	3 years 2 months 12 days
Aggregate Intrinsic Value	$ 15,181
Options vested as of end of period and expected to vest after end of period
Options vested and expected to vest (in shares)	1,710
Weighted average exercise price (in dollars per share)	$ 1.30
Weighted-Average Remaining Contractual Term (Years)	3 years 2 months 12 days
Aggregate Intrinsic Value	$ 15,181

XML

Stockholders' Equity and Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 5,503	$ 6,553
Cost of revenues
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	700	709
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	2,098	3,122
Sales, general and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 2,705	$ 2,722

XML

Leases - Narrative (Details)	Mar. 31, 2023	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Weighted-average remaining lease term for operating leases (in years)	8 years	8 years
Weighted-average discount rate for operating leases (as a percent)	3.60%	3.60%
Operating Leases, Facilities
Lessee, Lease, Description [Line Items]
Renewal lease term (in years)	15 years
Operating Leases, Facilities | Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term (in years)	1 month
Operating Leases, Facilities | Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term (in years)	12 years 2 months 12 days
Operating Leases, Automobiles and Equipment | Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term (in years)	2 months 12 days
Operating Leases, Automobiles and Equipment | Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term (in years)	4 years 3 months 18 days

XML

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating lease expense	$ 921	$ 1,031
Short-term lease expense	93	121
Variable and other lease expense	225	194
Lease expense	$ 1,239	$ 1,346

XML

Leases - Future Minimum Payments Under Non-Cancelable Operating Leases (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Leases [Abstract]
2023	$ 2,658
2024	3,232
2025	2,067
2026	1,654
2027	1,655
Thereafter	6,806
Total minimum lease payments	18,072
Less: interest	(2,495)
Present value of net minimum lease payments	15,577
Less: current portion of lease liabilities	(3,001)	$ (2,758)
Total long-term lease liabilities	$ 12,576	$ 12,852

XML

Segment Information - Narrative (Details)	3 Months Ended
	Mar. 31, 2023 segment
Segment Reporting [Abstract]
Number of reportable segments	2

XML

Segment Information - Operating Results (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Revenue	$ 54,091	$ 64,459
Gross profit	$ 14,263	$ 16,177
Gross margin	26.40%	25.10%
Operating Segments | Laser Products
Segment Reporting Information [Line Items]
Revenue	$ 41,107	$ 51,061
Gross profit	$ 14,281	$ 16,002
Gross margin	34.70%	31.30%
Operating Segments | Advanced Development
Segment Reporting Information [Line Items]
Revenue	$ 12,984	$ 13,398
Gross profit	$ 682	$ 884
Gross margin	5.30%	6.60%
Corporate and Other
Segment Reporting Information [Line Items]
Revenue	$ 0	$ 0
Gross profit	$ (700)	$ (709)

XML

Net Loss per Share (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	2,419	3,403
Restricted stock units and awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	845	1,313
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,574	2,090

XML

Subsequent Event (Details) - USD ($) $ in Thousands	May 04, 2023	Mar. 31, 2023	Dec. 31, 2022
SubsequentEventTable [Line Items]
Contract with customer, liability		$ 2,511	$ 2,455
High Energy Laser Prototype | Subsequent Event
SubsequentEventTable [Line Items]
Contract with customer, liability	$ 86,000